Diagnostic cartridge and analysis device using same

The integrally injection-molded diagnostic cartridge with a simplified fluid path and reagent supply system addresses low detection efficiency and high manufacturing costs, achieving accurate and efficient diagnostic analysis with uniform reagent distribution.

WO2026235438A1PCT designated stage Publication Date: 2026-11-12RAPIGEN
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/KR2026/096408
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2026-03-19
Filing Date
2026-04-28
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing diagnostic technologies face challenges of low detection efficiency, complex manufacturing costs, and variability in reagent supply due to separate processing devices and complex fluid path structures, leading to increased costs and difficulty in precise measurement.

Method used

A diagnostic cartridge with an integrally injection-molded cartridge body and reaction chamber, featuring simplified fluid paths and reagent supply mechanisms, including a reagent supply unit with a perforation structure for uniform reagent distribution and a thermoplastic material for sealing, along with a magnetic bead transport system for sample processing.

Benefits of technology

The solution enables high detection efficiency and accuracy with a compact structure at reduced manufacturing costs, ensuring uniform reagent supply and precise measurement while simplifying the manufacturing process and reducing fluid leakage risks.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure KR2026096408_12112026_PF_FP_ABST
    Figure KR2026096408_12112026_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to a diagnostic cartridge and an analysis device using the diagnostic cartridge. The diagnostic cartridge according to the present invention comprises: a cartridge body portion; and a reaction chamber portion which is provided on one side of the cartridge body portion and in which a fluid transferred from the cartridge body portion through a flow path reacts with a reaction solution accommodated in a chamber therein, wherein the cartridge body portion has therein a plurality of compartments for accommodating a supplied sample and reagent therein, the plurality of compartments being open at the upper surfaces thereof and arranged in parallel, at least one of the plurality of compartments is configured to accommodate a plurality of magnetic beads therein, a space communicating with the inside of the plurality of compartments is formed above the plurality of compartments so as to allow the magnetic beads to be transported between the plurality of compartments by using a magnetic body, and the cartridge body portion and the reaction chamber portion are integrally injection-molded.
Need to check novelty before this filing date? Find Prior Art

Description

Diagnostic cartridge and analysis device using the same

[0001] The present invention relates to a diagnostic cartridge and an analysis device using the same, and more specifically, to a diagnostic cartridge and an analysis device using the same that can be commonly used for various medical diagnostic analyses using microfluidics, such as molecular diagnostics or immunodiagnostics.

[0002] In modern times, with the advancement of biotechnology, it has become possible to interpret the causes of diseases at the genetic level, and accordingly, the demand for the manipulation of biological samples and biochemical analysis to cure or prevent human diseases is gradually increasing.

[0003] In general, diagnostic analysis of biological samples is a test that determines whether a disease is present by detecting or measuring specific indicator substances from biological samples such as blood, urine, and saliva. Such diagnostic analysis of biological samples is widely used not only for diagnostic purposes, such as identifying etiology, treatment, prevention, and prediction, but also in various fields including the development of personalized new drugs, forensic medicine, and the detection of endocrine disruptors.

[0004] In order to perform quantitative diagnostic analysis on such biological samples, processing steps (purification, washing) of the biological samples must be carried out. Conventionally, separate processing devices were provided for each of these processing steps, and biological samples had to be moved to another processing device after processing was completed in one device. This required a long time for processing, which resulted in a problem of low detection efficiency.

[0005] In order to solve the problem of low detection efficiency mentioned above, Patent Document 1 discloses a technology in which a plurality of branched passages are created in the piston head so that the piston head rotates and directly sucks in the reagent contained in the chamber and mixes it within the piston's internal space.

[0006] In addition, Patent Document 2 discloses a technique for processing by transporting genes using magnetic beads between a plurality of compartments provided within the cartridge body of a diagnostic cartridge.

[0007] [Prior Art Literature]

[0008] [Patent Literature]

[0009] (Patent Document 1) Patent Document 1: U.S. Registered Patent No. 6,374,684 (Published April 23, 2002)

[0010] (Patent Document 2) Patent Document 2: Korean Published Patent No. 10-2025-0028956 (Published March 4, 2025)

[0011] In the case of Patent Document 1, there was a problem in that the manufacturing cost of the piston increased because it was necessary to create multiple branched passages inside the piston head.

[0012] In addition, Patent Document 2 adopts a structure in which the cartridge body and the reaction chamber are composed of separate bodies and are physically coupled to each other. Therefore, as disclosed in Patent Document 2, in order to form a fluid path through which a fluid containing a biological sample flows between the cartridge body and the reaction chamber while maintaining airtightness between the cartridge body and the reaction chamber, it is necessary to form a fluid path having a curve within the cartridge body. Consequently, while the internal structure of the cartridge body becomes complex, there was a problem of increased manufacturing costs because the cartridge body and the reaction chamber had to be manufactured separately.

[0013] In addition, in the case of Patent Document 2, a perforating pin is provided within the cartridge body to perforate the sealing film of the reagent supply unit so that the reagent is supplied from the reagent supply unit into the compartment. However, according to the above structure, even if the perforating pin penetrates the sealing film and enters the reagent supply unit, it was difficult to perforate a hole sufficient for the entire amount of reagent stored in the reagent supply unit to fall into the compartment by its own weight. Consequently, not only was it difficult to supply a sufficient amount of reagent into the compartment, but there was also a problem in that the amount of reagent supplied from the reagent supply unit varied for each compartment, making precise measurement difficult.

[0014] The present invention has been devised to solve the problems of the aforementioned prior art and aims to provide a multi-purpose diagnostic cartridge and an analysis device using the same that have high detection efficiency and detection accuracy, while having a compact structure and being manufactureable at a low manufacturing cost.

[0015] According to one embodiment of the present invention for achieving the above objectives, a diagnostic cartridge comprises a cartridge body and a reaction chamber provided on one side of the cartridge body to react a fluid delivered from the cartridge body through a flow path with a reaction solution contained in a chamber therein. The cartridge body has an open top surface and a plurality of compartments arranged side by side to contain a supplied sample and reagent. A plurality of magnetic beads are contained in at least one of the plurality of compartments, and above the plurality of compartments, a space communicating with the interior of the plurality of compartments is formed to allow the magnetic beads to be transported between the plurality of compartments using a magnetic material, and the cartridge body and the reaction chamber are injection molded integrally.

[0016] According to one embodiment of the present invention, the cartridge body and the reaction chamber forming the diagnostic cartridge are integrally injection molded, thereby simplifying the manufacturing process and reducing manufacturing costs compared to a method in which the two are manufactured separately and then combined. Furthermore, there is no concern regarding leakage of fluids, such as biological samples, at the connection point between the cartridge body and the reaction chamber, and the fluid path structure for connecting the two can also be simplified.

[0017] According to the present invention, injection molding can be performed such that the bottom surface of the cartridge body corresponding to a compartment directly connected to the chamber of the reaction chamber through a flow path among a plurality of compartments and the bottom surface of the reaction chamber are on the same plane.

[0018] According to the present invention, a passage connecting the chamber and the chamber within the reaction chamber can be easily formed simply by injection molding the cartridge body and the reaction chamber so that the concave portion forming the inlet passage communicates with the internal space of the compartment.

[0019] According to the present invention, the reaction chamber portion is a plate-shaped portion in which at least one of its upper and lower surfaces is covered by a cover, and the flow path and the chamber may be formed by injection molding inwardly concavely from the surface of the plate-shaped portion or by injection molding to penetrate the plate-shaped portion.

[0020] According to the present invention, a flow path and / or chamber can be simply formed using a through-hole or a recess formed in an injection-molded product, and the exposed portion due to the above structure can be covered with a separate cover to maintain airtightness.

[0021] According to the present invention, the cartridge body is injection molded so that the lower surface of a plurality of compartments is open downward, and may further be provided with a cover that can cover the open lower surface.

[0022] According to the present invention, even if the material of the injection-molded product constituting the cartridge body is not suitable for ultrasonic transmission, the cover is made of a material suitable for ultrasonic transmission so that ultrasonic waves can be effectively transmitted from the outside into the compartment through the open bottom surface covered by the cover.

[0023] According to the present invention, the flow path comprises an inlet flow path, one end of which is fluidly connected to a compartment of the cartridge body and the other end of which is fluidly connected to a chamber, and an outlet flow path, one end of which is fluidly connected to a chamber and the other end of which is connected to an external negative pressure generating device. At least one of the inlet flow path and the outlet flow path may be sealed by an obstacle made of a thermoplastic material.

[0024] According to the present invention, prior to diagnosis, the thermoplastic material is kept in a solidified state to seal the flow path, while at the start of diagnosis, the thermoplastic material is melted through heating or the like to release the sealed state of the flow path.

[0025] According to the present invention, the reaction chamber may further comprise an injection port capable of injecting a thermoplastic material from the outside and a sealed channel having one end connected to the injection port and the other end communicating with an inlet channel and an outlet channel.

[0026] According to the present invention, a thermoplastic material can be easily injected into the reaction chamber through an injection port, and the inlet and outlet channels can be sealed through branched sealed channels. Additionally, when the thermoplastic material is dissolved, the liquid thermoplastic material can be discharged to form a channel leading to the inlet channel, sealed channel, and outlet channel.

[0027] According to the present invention, at least one of the inlet channel and the outlet channel may be composed of a curved line comprising at least three curves bent at a predetermined angle.

[0028] According to the present invention, a plurality of bends act as obstacles to the flow of the reaction liquid flowing out through the flow path, thereby enabling the suppression of the reaction liquid outflow caused by temperature changes during the heating process of the reaction liquid.

[0029] According to the present invention, the cartridge body is configured so that a magnetic body can enter the interior of the compartment from the open upper surface of the compartment through the space above the compartment.

[0030] According to the present invention, the magnetic body can come into direct contact with the magnetic bead contained in the compartment within the compartment, thereby making the transport of the magnetic bead easier.

[0031] According to the present invention, the device further comprises a reagent supply unit inserted and seated through an open upper portion of the cartridge body, wherein the reagent supply unit has a hollow shape surrounded by walls corresponding to each compartment of the cartridge body, and a plurality of reagent chambers are formed side by side with their lower ends sealed by a sealing film while a reagent to be supplied to each compartment within the cartridge body is contained inside the hollow, and above each compartment, a perforation portion of the hollow surrounded by walls may be provided to perforate the sealing film.

[0032] According to the present invention, during the process of combining the reagent supply unit and the cartridge body, the reagent contained in the reagent supply unit can be supplied into the cartridge body, and after combination, the internal space of the reagent supply unit and the cartridge body can be sealed. Therefore, the exposure of the reagent or sample to the outside before or during the diagnostic process can be suppressed. In addition, since the perforation part has a hollow shape surrounded by a wall, when it penetrates the sealing film and enters each reagent chamber, it can come into contact with the sealing film over the entire perimeter of the wall constituting the perforation part (130). Therefore, a perforation of sufficient size can be effectively formed so that the entire amount of reagent (11) contained in each reagent chamber can fall into the compartment through the perforated hole in the sealing film due to the weight of the reagent.

[0033] According to the present invention, when viewed from above, the outer surface of the wall of the hollow perforation may have a shape corresponding to the inner surface of the hollow of the reagent chamber.

[0034] According to the present invention, a sealing film can be effectively perforated, and the entire amount of reagent falling when the sealing film is perforated can be effectively introduced into the hollow of the perforation.

[0035] According to the present invention, one end may be connected to one of the wall portions constituting the perforation portion, and the other end may be connected to a side wall constituting the compartment, and may further be provided with an inclined portion that extends downward at an angle to form a path through which the reagent flows from the reagent chamber into the compartment when the sealing film is perforated by the perforation portion.

[0036] According to the present invention, a reagent that has fallen into the hollow of the perforation part can be easily guided into the compartment of the cartridge body part through the inclined part.

[0037] According to the present invention, a cartridge body is injection molded so that the lower portion of the compartment is open, and when the cartridge body is viewed from above, the side wall of the compartment connected to the inclined portion may be offset toward the inclined portion from the wall portion of the perforation located above the side wall.

[0038] According to the present invention, since the lower part of the compartment is open and the side wall of the compartment is offset from the wall of the perforation when viewed from above, it is possible to prevent undercuts caused by the complex structure of the compartment and the perforation during injection molding of the cartridge body.

[0039] According to the present invention, an edge portion may be formed on the upper surface of the wall portion of the hollow perforation portion, with a pointed portion protruding toward the sealing film of the reagent chamber.

[0040] According to the present invention, the upper surface of the perforation portion has a sharp blade structure, so that the sealing film of the reagent chamber can be effectively cut.

[0041] According to the present invention, the pointed portion of the edge portion is formed along the perimeter of the wall portion of the hollow perforation when viewed from above, and the edge portion may have an inclined portion formed to slope downward from the pointed portion toward the interior of the hollow perforation.

[0042] According to the present invention, after the sealing film of the reagent chamber is cut by the blade structure of the edge portion, when the reagent stored in the reagent chamber falls toward the compartment of the cartridge body portion, the reagent can be effectively guided to flow into the hollow within the perforation portion through the inclined portion.

[0043] According to the present invention, each compartment of the reagent supply unit may be configured such that the lower surface facing the perforation is formed flat, and the heights of a pair of opposing walls among the walls of the hollow perforation are configured differently, so that another pair of walls extending between the pair of walls forms an inclined portion.

[0044] According to the present invention, it is possible to limit the cutting direction and range when the sealing film of the reagent chamber is cut by the edge portion formed on the upper surface of the perforation portion, and the area of ​​force received by the sealing film is reduced so that the sealing film can be cut with less force. Accordingly, the cartridge body portion and the reagent supply portion can be coupled more smoothly.

[0045] According to the present invention, an edge portion can be prevented from being formed on the upper surface of the lower wall portion among a pair of wall portions configured with different heights of perforations.

[0046] According to the present invention, when the sealing film is cut while the reagent supply unit and the cartridge body unit are combined, it is possible to control the process so that only a specific portion of the sealing film corresponding to the perforation where no edge is formed is not cut. In this case, a portion of the sealing film that is not cut climbs up the wall of the reagent chamber and adheres to the wall. Therefore, it is possible to effectively prevent a portion of the sealing film from blocking the falling of the reagent by causing the sealing film to be cut unevenly by the perforation.

[0047] According to the present invention, the edge portion may further have an inclined portion formed to slope downward from the pointed portion toward the outside of the hollow of the perforation portion.

[0048] According to the present invention, even when a gap occurs between the compartment of the cartridge body and the reagent chamber of the reagent supply unit, the wall of the reagent chamber of the reagent supply unit moves along the inclined surface of the edge, thereby effectively inducing the perforation to enter the reagent chamber.

[0049] According to the present invention, the pointed portion of the edge may have at least one sawtooth-shaped protrusion protruding toward the sealing film of the reagent chamber.

[0050] According to the present invention described above, the sealing film of a reagent chamber can be effectively perforated using a sawtooth-shaped protrusion, and the sealing film can be effectively cut by continuously cutting the cut portion along the pointed portion.

[0051] According to the present invention, the reaction chamber portion is a plate-shaped portion in which at least one of its upper and lower surfaces is covered by a cover, and the flow path is formed by injection molding inwardly concavely from the surface of the plate-shaped portion or by injection molding to penetrate the plate-shaped portion, and the chamber may be a hollow member formed by injection molding to protrude downward from the lower surface of the plate-shaped portion, with the bottom surface of the chamber positioned lower than the lower surface of the plate-shaped portion, and the upper portion being open through the upper surface of the plate-shaped portion.

[0052] According to the present invention, while maintaining a sufficient amount of reaction liquid within the chamber for the reaction, the surface of the reaction liquid can be kept lower than the upper surface of the reaction chamber, thereby preventing the reaction liquid within the chamber from expanding and leaking through the flow path before causing a reaction during the heating process.

[0053] According to the present invention, a chamber for storing a reaction solution may be structured such that the lower side is open and the open lower side is covered by a cover.

[0054] According to the present invention, a chamber can be formed by injection molding in a shape where the upper and lower ends of the chamber are open, thereby allowing the chamber to have a shape that facilitates injection, and the bottom of the chamber can be easily formed by attaching a cover to the open lower surface after injection molding.

[0055] According to the present invention, the flow path includes an inlet flow path in which one end is fluidly connected to a compartment of the cartridge body and the other end is fluidly connected to a chamber, and an outlet flow path in which one end is fluidly connected to a chamber and the other end is connected to an external negative pressure generating device, and the inlet flow path may be equipped with a valve capable of opening and closing the inlet flow path.

[0056] According to the present invention, the flow path between the compartment within the cartridge body and the reaction chamber can be opened and closed via a valve. Therefore, before using the diagnostic cartridge, the flow path can be closed via the valve to effectively prevent moisture from the reaction chamber from being transferred to the freeze-dried reagent. Additionally, by closing the flow path via the valve during reagent amplification, the evaporation of the reagent can be effectively suppressed by preventing the evaporated reagent from leaking into the cartridge body through the flow path.

[0057] According to the present invention, the valve may comprise a valve seat that opens and closes the interior of a flow path by moving back and forth toward a flow path, a piston portion extending in an upward and downward direction from the valve seat, and a piston head provided at the end of the piston portion facing the valve seat.

[0058] According to the present invention, by operating the piston of the valve from the outside of the diagnostic cartridge, the opening and closing of the flow path between the compartment and the reaction chamber within the cartridge body part inside the diagnostic cartridge can be effectively controlled.

[0059] According to the present invention, a negative pressure generating device may be configured to generate a pressure difference between an inlet passage and an outlet passage within a reaction chamber by grasping and extending the piston head of a piston connected to an outlet passage of a reaction chamber.

[0060] According to the present invention, by operating the piston of the negative pressure generating device outside the diagnostic cartridge, negative pressure can be effectively generated between the inlet path and the outlet path.

[0061]

[0062] According to the present invention, the reaction chamber portion comprises a plurality of chambers, and the flow path includes a plurality of inlet flow paths connected to each of the compartments of the cartridge body portion and the plurality of chambers, and each of the plurality of inlet flow paths may include a first inlet flow path with one end connected to a compartment, a second inlet flow path located above the first inlet flow path when viewed from the side and with one end connected to a chamber, and a third inlet flow path connecting the first inlet flow path and the second inlet flow path and extending upward.

[0063] According to the present invention, fluids passing through a plurality of inlet passages connecting the compartment and each chamber can be made to arrive almost simultaneously near the connection point between the third inlet passage and the second inlet passage, thereby allowing nearly equal amounts of fluid to be supplied to each chamber. Consequently, more accurate reagent dispensing can be achieved, further enhancing the accuracy of the reaction.

[0064] According to the present invention, the diagnostic cartridge can be used for molecular diagnosis or immunodiagnosis.

[0065] According to the present invention, a plurality of different diagnoses can be performed using a diagnostic cartridge and an analysis device of the same type.

[0066] According to the present invention, an information display unit including information regarding at least one of the type of diagnosis performed using the diagnostic cartridge, the shape of the diagnostic cartridge, the type of sample contained within the diagnostic cartridge, and the type of reagent contained in the compartment may be attached to the diagnostic cartridge.

[0067] According to the present invention described above, by reading an information display unit using a sensor or the like provided in the analysis device, the operating parameters necessary to drive the analysis device when performing an analysis using the corresponding diagnostic cartridge can be automatically set based on the information contained in the information display unit.

[0068] An analysis device according to one embodiment of the present invention for achieving the above purpose is an analysis device that performs a diagnosis using the aforementioned diagnostic cartridge, and comprises: a stage on which the diagnostic cartridge is mounted; a magnetic bead transfer module for transferring magnetic beads within the diagnostic cartridge using a magnetic material; a fluorescence detection module for optically detecting fluorescence of a plurality of wavelengths resulting from the reaction of a reaction liquid within a reaction chamber; an ultrasonic generation module for providing ultrasonic waves into the interior of at least one of the cartridge body and the reaction chamber; and a control unit for controlling at least one of the stage, the magnetic bead transfer module, the fluorescence detection module, and the ultrasonic generation module.

[0069] According to the present invention described above, various types of diagnoses can be performed through a single analysis device using the aforementioned diagnostic cartridge.

[0070] According to the present invention, the analysis device further includes a temperature control module for controlling the temperature inside the reaction chamber of the diagnostic cartridge, and the temperature control module may include a first temperature control unit for transferring or recovering thermal energy inside the chamber of the reaction chamber and a second temperature control unit for transferring or recovering thermal energy to a thermoplastic material that seals the flow path of the reaction chamber.

[0071] According to the present invention described above, the reaction solution and the thermoplastic material contained in the chamber of the reaction chamber can be controlled to different temperatures.

[0072] According to the present invention, the control unit receives information regarding at least one of the type of diagnosis performed using the diagnostic cartridge, the shape of the diagnostic cartridge, the type of sample contained in the diagnostic cartridge, and the type of reagent contained in the compartment by receiving direct input from a user through an input unit or by reading an information display unit displayed on the diagnostic cartridge through a sensor, and can control at least one of a stage, a magnetic bead transfer module, a fluorescence detection module, and an ultrasonic generation module based on the received information.

[0073] According to the present invention described above, it is possible to appropriately set the operating parameters of each module of the analysis device according to the physical characteristics of the diagnostic cartridge, the types of reagents and samples used, and the types of analysis performed.

[0074] A diagnostic cartridge according to the present invention for solving the above problems is a diagnostic cartridge that uses magnetic beads to transfer a sample between a plurality of compartments containing a reagent within a cartridge body and performs processing, and transfers the processed sample to a reaction chamber to react with a reaction solution, wherein the cartridge body and the reaction chamber can be injection molded as a single unit.

[0075] According to one embodiment of the present invention, the cartridge body and the reaction chamber forming the diagnostic cartridge are integrally injection molded, thereby simplifying the manufacturing process and reducing manufacturing costs compared to a method in which the two are manufactured separately and then combined. Furthermore, there is no concern regarding leakage of fluids, such as biological samples, at the connection point between the cartridge body and the reaction chamber, and the fluid path structure for connecting the two can also be simplified.

[0076] According to the present invention, it is possible to manufacture a cartridge with a compact structure and low manufacturing cost while enabling analysis with high detection efficiency and detection accuracy.

[0077] Furthermore, according to the present invention, a diagnostic cartridge that can be universally used for molecular diagnosis and immunodiagnosis can be provided. Additionally, by detecting an information display unit on the diagnostic cartridge, the type of diagnosis using the diagnostic cartridge and the setting of driving control parameters for each module required for diagnosis can be automatically performed, thereby reducing the burden on the user in operating the analysis device and reducing the possibility of misdiagnosis.

[0078] FIG. 1 is a perspective view showing the external appearance of a diagnostic cartridge according to a preferred embodiment of the present invention.

[0079] FIGS. 2a to 2c are top, side, and bottom views of the diagnostic cartridge shown in FIG. 1.

[0080] FIG. 3 is an enlarged perspective view showing the configuration of the reaction chamber section of the diagnostic cartridge illustrated in FIG. 1.

[0081] FIG. 4 is an enlarged perspective view of the chamber portion of the reaction chamber portion shown in FIG. 3.

[0082] FIG. 5 is a bottom view showing the configuration of the reaction chamber section illustrated in FIG. 3,

[0083] FIGS. 6A and 6B are drawings for explaining the positional relationship between the compartment of the cartridge body and the flow path of the reaction chamber.

[0084] FIG. 7 is an enlarged perspective view showing the configuration of a reaction chamber section according to a preferred embodiment of the present invention.

[0085] FIG. 8 is an enlarged perspective view of the chamber portion of the reaction chamber portion shown in FIG. 7.

[0086] FIG. 9 is an enlarged perspective view of a portion of a diagnostic cartridge with a valve installed according to a preferred embodiment of the present invention.

[0087] FIG. 10 is a diagram showing the results of testing the reagent supply status through each flow path when supplying a reagent to each chamber using a diagnostic cartridge according to a preferred embodiment of the present invention shown in FIG. 9.

[0088] FIG. 11 is an exploded perspective view showing the reagent supply part and piston part of a diagnostic cartridge in a detached state according to a preferred embodiment of the present invention.

[0089] FIG. 12 is a perspective view showing the state in which the reagent supply unit and piston unit shown in FIG. 11 are assembled to the cartridge body.

[0090] FIG. 13a is a side view showing the state before the reagent supply unit illustrated in FIG. 11 is assembled to the cartridge body, and FIG. 13b is a side view showing the state after the reagent supply unit is assembled to the cartridge body.

[0091] FIG. 14 is a perspective view of the upper surface of the reagent supply unit shown in FIG. 11 facing upward.

[0092] FIG. 15 is a perspective view of the lower surface of the reagent supply unit shown in FIG. 11 facing upward.

[0093] FIG. 16 is a broken perspective view showing the state before the cartridge body and reagent supply unit shown in FIG. 11 are combined.

[0094] FIG. 17 is a broken perspective view showing the completed state of the combination of the cartridge body and the reagent supply unit illustrated in FIG. 11.

[0095] FIGS. 18a and FIGS. 18b are a broken perspective view and a cross-sectional view illustrating the process of combining the cartridge body and the reagent supply unit shown in FIG. 11 and the reagent delivery process at that time.

[0096] FIG. 19a is a broken perspective view showing the internal structure of a diagnostic cartridge according to a preferred embodiment of the present invention, FIG. 19b is a partial perspective view showing an enlarged perforation portion of the diagnostic cartridge shown in FIG. 19a, FIG. 19c is a cross-sectional view showing the state in which the cartridge body portion and the reagent supply portion of the diagnostic cartridge shown in FIG. 19a are assembled, and FIG. 19d is a drawing for explaining the flow of reagent in the state shown in FIG. 19a.

[0097] FIG. 20 is an exploded perspective view of a diagnostic cartridge according to another preferred embodiment of the present invention.

[0098] FIG. 21 is a broken perspective view for illustrating the interior of the cartridge body portion of the diagnostic cartridge shown in FIG. 20.

[0099] FIG. 22 is a cross-sectional view showing the state in which the cartridge body and the reagent supply unit of the diagnostic cartridge shown in FIG. 21 are assembled.

[0100] FIG. 23 is a drawing for showing the cross-sectional shape of the edge portion formed in the perforation portion shown in FIG. 21.

[0101] FIGS. 24a and FIGS. 24b are drawings for explaining the difference in the positioning effect of a reagent chamber depending on the presence or absence of the inclined surface of the edge portion shown in FIG. 23.

[0102] FIGS. 25a to 25c are drawings for illustrating the flow of a reagent from the cartridge body to the reaction chamber according to the piston operation of the syringe shown in FIG. 11.

[0103] FIGS. 26a to 26c are drawings for explaining the process of transferring a reagent from the reagent supply unit shown in FIG. 11 to the cartridge body and the process of transferring a nucleic acid within the cartridge body.

[0104] FIG. 27 is a diagram illustrating a diagnostic cartridge according to a preferred embodiment of the present invention and a nucleic acid delivery process within a cartridge body using the same.

[0105] FIG. 28 is a block diagram illustrating the configuration of an analysis device according to a preferred embodiment of the present invention.

[0106] FIGS. 29a and FIGS. 29b are a top view and a side view of an analysis device according to a preferred embodiment of the present invention.

[0107] FIG. 30 is an enlarged front view of the stage, magnetic bead transfer module, and ultrasonic generation module portions of the configuration of the analysis device shown in FIG. 29a and FIG. 29b.

[0108] FIG. 31 is an enlarged front view of the stage, sound pressure generation module, temperature control module, and fluorescence detection module portions of the configuration of the analysis device shown in FIG. 29a and FIG. 29b.

[0109]

[0110] Each symbol represents the following:

[0111] 1: Diagnostic cartridge 2: Stage

[0112] 3: Magnetic bead transfer module 3a: Transfer drive unit

[0113] 4: Fluorescence detection module 5: Ultrasonic generation module

[0114] 6: Temperature control module 7: Negative pressure generation module

[0115] 8: Control unit 8a: Input unit

[0116] 8b: Sensor 9: Door

[0117] 10: Reaction solution 11: Reagent

[0118] 12: Magnetic beads 13: Nucleic acid (DNA)

[0119] 14: Magnetic material 100: Cartridge main body

[0120] 101: Lower cover of cartridge body 110a, 110b, 110c, 110d, 110e: Compartments

[0121] 111: Compartment wall 120: Information display

[0122] 130: Sky section 131: Sky section wall section

[0123] 132: Inclined section 133: Reagent supply port

[0124] 140, 141a, 141b, 141c: Edge portion 140a: Point portion

[0125] 142a: Slope 140b, 142b, 143b: Slope section

[0126] 140c: Serrated protrusion 200: Reaction chamber section

[0127] 201: Upper cover of the reaction chamber 202: Lower cover of the reaction chamber

[0128] 210: Chamber 211a, 211b, 211c: Chamber

[0129] 260: Valve 261: Valve Seat

[0130] 262: Piston section 263: Piston head

[0131] 220: Euro 221: Entrance Euro

[0132] 221a: 1st Entrance Euro 221b: 3rd Entrance Euro

[0133] 221c: Second Entrance Euro 222: Exit Euro

[0134] 223: Sealed Euro 224: Bent

[0135] 230: Exit 240: Thermoplastic material

[0136] 241: Injection port 250: Negative pressure generating device (syringe)

[0137] 251: Piston 252: Piston head

[0138] 300: Reagent supply unit 301: Sample inlet

[0139] 302: Sample inlet cover 303: Sample outlet

[0140] 304: Sample outlet cover 310: Reagent chamber

[0141] 311: Reagent chamber wall 312: Sealing film

[0142] The present invention will be explained in more detail below through the attached drawings and embodiments.

[0143] In the following embodiments, illustrations and descriptions have been omitted except for parts that are essential to explaining the invention. Throughout the specification, identical or similar elements are given the same reference numerals, and detailed descriptions thereof are omitted without repetition.

[0144] Structure of the Diagnostic Cartridge

[0145] FIG. 1 is a perspective view showing the appearance of a diagnostic cartridge according to a preferred embodiment of the present invention, and FIG. 2a to 2c are top, side, and bottom views of the diagnostic cartridge shown in FIG. 1.

[0146] As illustrated in FIGS. 1 and FIGS. 2a to 2c, the diagnostic cartridge (1) according to the present invention comprises a cartridge body (100) having a plurality of compartments (110a, 110b, 110c, 110d, 110e) for receiving a sample and / or reagent which is a microfluid inside, and a reaction chamber (200) that reacts a fluid delivered from the cartridge body (100) through a flow path (220) with a reaction liquid (10) contained in a chamber (210) inside. Here, the cartridge body (100) and the reaction chamber (200) of the diagnostic cartridge (1) according to the present invention are integrally formed by injection molding. That is, the cartridge body (100) and the reaction chamber (200) are not manufactured separately and then assembled, but are integrally formed through a single injection molding using a single mold. Preferably, the material of the cartridge body (100) and the reaction chamber (200) may be a transparent or translucent plastic material.

[0147] Hereinafter, the cartridge body part (100) of a diagnostic cartridge (1) according to a preferred embodiment of the present invention will be described first based on the contents of FIGS. 1 and FIGS. 2a to 2c.

[0148] The cartridge body (100) is formed in a cylindrical shape having a bottom and an open top, and inside the cylindrical shape, a plurality of compartments (110a, 110b, 110c, 110d, 110e) with an open top surface are arranged side by side in a predetermined direction to accommodate supplied samples and reagents. FIG. 2a illustrates that the plurality of compartments (110a, 110b, 110c, 110d, 110e) are arranged side by side in the length direction of the cartridge body (100), but the present invention is not limited to the above-described embodiment; for example, some of the compartments may also be arranged side by side in the width direction of the cartridge body (100). In the cartridge body (100), treatment of the samples is performed according to the reagents accommodated in each of the plurality of compartments (110a, 110b, 110c, 110d, 110e). For example, in the structure illustrated in FIG. 2a, according to the arrangement order of the plurality of compartments (110a, 110b, 110c, 110d, 110e), processing can be performed in the order from the compartment (110a) furthest from the reaction chamber (200) to the compartment (110b) closest to the reaction chamber (200).

[0149] A plurality of compartments (110a, 110b, 110c, 110d, 110e) have a hollow tubular shape surrounded by compartment walls (111). According to the embodiment illustrated in FIG. 7, the compartment walls (111) constituting each of the plurality of compartments (110a, 110b, 110c, 110d, 110e) are composed of two pairs of walls arranged facing each other, so that when viewed from above, the outer surface has a rectangular cross-section, but the present invention is not limited to the above-described embodiment. For example, each compartment may have a tubular shape in which the outer surface and / or inner surface formed by the compartment walls is circular when viewed from above. As illustrated in FIG. 25a, any one of the multiple compartments (110a, 110b, 110c, 110d, 110e), preferably the compartment (110a) furthest from the reaction chamber (200), is provided with magnetic beads (12) to assist in mixing the sample to be diagnosed and the reagent (11) and to transport nucleic acid (13) extracted from the sample to each compartment. And any one of the multiple compartments (110a, 110b, 110c, 110d, 110e), preferably the compartment (110e) closest to the reaction chamber (200), is fluidly connected to the chambers (210a, 210b, 210c) of the reaction chamber (200) through a flow path (220). Through this, the biological sample that has undergone the final processing in the corresponding compartment (110e) can be supplied to the chambers (210a, 210b, 210c) of the reaction chamber section (200) through the flow path (220). Meanwhile, the plurality of compartments (110a, 110b, 110c, 110d, 110e) are made so that at least the upper part is open so that the magnetic bead (12) can enter and exit and move through the space above them.Preferably, as shown in FIG. 2c, the cartridge body (100) may be injection molded so that the lower portion of at least some of the multiple compartments (110a, 110b, 110c, 110d, 110e) is also open to the outside (i.e., the internal space of the multiple compartments communicates with the outside through a through opening formed on the bottom surface of the cartridge body (100). In this case, a lower cover (101) of the cartridge body may be provided to cover the open lower portions of the multiple compartments (110a, 110b, 110c, 110d, 110e). As described below, it is preferable that the lower cover (101) of the cartridge body be formed in the form of a thin metal film so that ultrasonic waves generated by an external ultrasonic generating module (5) can be transmitted to the reagent inside the compartment through the lower cover (101) of the cartridge body. For example, the lower cover (101) of the cartridge body may be an aluminum film attached to the bottom surface of the cartridge body (101). Additionally, a removable sealing film may be attached to the upper surface of the partition wall (111) of each compartment (110a, 110b, 110c, 110d, 110e) so that the reagent contained in each compartment (110a, 110b, 110c, 110d, 110e) is not exposed to the outside before diagnosis.

[0150] Meanwhile, on one side of the cartridge body (100), an information display unit (120) may be attached that includes information regarding at least one of the following: the type of diagnosis performed using the diagnostic cartridge (1), the shape of the diagnostic cartridge (1), the type of sample contained within the diagnostic cartridge (1), and the type of reagent contained in a plurality of compartments (110a, 110b, 110c, 110d, 110e). The information display unit (120) may be a barcode that can be read through a sensor (8b), such as a barcode reader, of an analysis device. In the embodiment illustrated in FIG. 2b, the information display unit (120) is attached to one side of the cartridge body (100), but the present invention is not limited to the above-described embodiment. For example, the information display unit (120) may be attached to the surface of the reaction chamber (200) rather than the cartridge body (100). Alternatively, the information display unit (100) may be provided on a bottom surface facing the stage (2) of the analysis device on which the diagnostic cartridge (1) is placed. In this case, if a sensor (8b) capable of reading the information display unit is provided on the stage (2), it becomes possible to read the information contained in the information display unit (100) through the sensor (8b) during the operation of placing the information display unit (100) on the stage (2).

[0151] FIG. 3 is an enlarged perspective view showing the configuration of the reaction chamber section of the diagnostic cartridge illustrated in FIG. 1, FIG. 4 is an enlarged perspective view showing the chamber section of the reaction chamber section illustrated in FIG. 3, FIG. 5 is a bottom view showing the configuration of the reaction chamber section illustrated in FIG. 3, and FIG. 6a and FIG. 6b are drawings for explaining the positional relationship between the compartment of the cartridge body section and the flow path of the reaction chamber section. FIG. 3 to FIG. 6a are illustrated with the reaction chamber section upper cover (201) and reaction chamber section lower cover (202), which are attached to the surface and back surface of the reaction chamber section, excluded for ease of explanation.

[0152] Hereinafter, a reaction chamber portion (200) of a diagnostic cartridge (1) according to a preferred embodiment of the present invention will be described based on the contents of FIGS. 3 to 6b.

[0153] As illustrated in FIG. 3, the reaction chamber portion (200) may have a plate shape protruding from one side of the cartridge body portion (100). The reaction chamber portion (200) includes at least one chamber (210a, 210b, 210c) for receiving a reaction liquid (10) to react with a biological sample that has been processed in the cartridge body portion (100), and a flow path (220) for fluidly communicating the at least one chamber (210a, 210b, 210c) with a compartment (110e) where the final processing is performed in the cartridge body portion (100).

[0154] As illustrated in FIG. 4, the internal space of the chamber (210a, 210b, 210c) can be formed by injection molding the reaction chamber (200) such that a through hole is formed that penetrates the plate-shaped reaction chamber (200) in the vertical direction. Meanwhile, if the diagnosis using the diagnostic cartridge (1) is a molecular diagnosis, the reaction chamber (200) performs amplification of the nucleic acid extracted from the cartridge body (100), and the reaction solution (10) becomes a reaction solution for nucleic acid amplification. Furthermore, if the diagnosis using the diagnostic cartridge (1) is an immunological diagnosis, the reaction chamber (200) performs an immune reaction on the nucleic acid extracted and washed from the diagnostic cartridge (1), and the reaction solution (10) becomes an antigen that reacts with the nucleic acid.

[0155] As shown in FIG. 4, the flow path (220) may be formed by penetrating the reaction chamber section (200) in the vertical direction, similar to the chambers (210a, 210b, 210c), or it may be formed by a concave portion formed concavely from the surface of the reaction chamber section (200). Meanwhile, as shown in FIG. 6b, the upper cover (201) and the lower cover (202) of the reaction chamber section (200) are respectively attached to the surface and the back surface of the reaction chamber section (200) so as to cover the upper and lower surfaces of the chambers (210a, 210b, 210c) and / or the flow path (220) of the reaction chamber section (200). In the case of the upper cover (201) and lower cover (202) of the reaction chamber section, they may be formed as film-shaped members to facilitate heat transfer and ultrasonic transmission into the chambers (210a, 210b, 210c) of the reaction chamber section (200) through the covers. More preferably, the upper cover (201) and lower cover (202) of the reaction chamber section may be formed from a metal thin film material such as aluminum.

[0156] And, as illustrated in FIG. 5, the flow path (220) includes an inlet flow path (221) that is fluidly connected at one end to a compartment (110e) where the final processing is performed in the cartridge body (100) and at the other end to a chamber (210a, 210b, 210c), and an outlet flow path (222) that is fluidly connected at one end to a chamber (210a, 210b, 210c) and at the other end to an external negative pressure generating device (250) through an outlet (230). Accordingly, when the inside of the flow path (220) is made negative pressure by the negative pressure generating device (250), due to the pressure difference between the inlet flow path (221) and the outlet flow path (222), the biological sample processed in the compartment (110e) is sucked into the inlet flow path (221) and supplied into the chamber (210a, 210b, 210c).

[0157] At this time, as illustrated in FIG. 5, at least one of the inlet channel (221) and the outlet channel (222) may include a bending section (224) composed of a bending line comprising at least three bends bent at a predetermined angle. In the case of molecular diagnosis such as PCR diagnosis, since the binding and amplification of the polymerase and gene in the solution occur during the repetition of multiple cycles of temperature circulation, the temperature of the reaction solution (10) must be increased and decreased through the temperature control module (6) as described below. Meanwhile, there is a possibility that the reaction solution may flow back into the inlet channel (221) or the outlet channel (222) due to the generation of bubbles or changes in volume caused by the temperature change of the reaction solution (10) during the above-mentioned temperature control process. To solve this problem, the present invention provides a bending section (224) composed of a bending line comprising a plurality of bends as described above in at least one of the inlet channel (221) and the outlet channel (222). The above-mentioned bend (224) serves as an obstacle to the backflow of the reaction liquid (10) flowing out of the chambers (210a, 210b, 210c). Meanwhile, in order to more effectively secure the effect of the above-mentioned obstacle, it is more preferable that the angle of the bend in the bend (224) is such that the relative angle of the flow path (220) before and after the bend is 90 degrees or less.

[0158] Meanwhile, as described above, the flow path (220) includes an inlet flow path (221) in which one end is fluidly connected to a compartment (110e) where the final processing is performed in the cartridge body (100) and the other end is fluidly connected to a chamber (210a, 210b, 210c), and an outlet flow path (222) in which one end is fluidly connected to a chamber (210a, 210b, 210c) and the other end is connected to an external negative pressure generating device (250) through an outlet (230). Accordingly, there is a possibility that the reaction liquid (10) contained in the chamber (210a, 210b, 210c) may be exposed to the outside air through the compartment (110e) or the negative pressure generating device (250) before the diagnosis is performed. Accordingly, before performing the diagnosis, the flow path (220) is sealed so that the reaction liquid (10) contained in the chamber (210a, 210b, 210c) is isolated from the outside air, but when performing the diagnosis, it is necessary to open the flow path (220) to allow the inflow of the sample and the formation of negative pressure. To this end, in the present invention, the reaction chamber section (200) is configured such that, before the diagnosis is performed, at least one of the inlet flow path (221) and the outlet flow path (222) is sealed by an obstacle made of a thermoplastic material. In the case of a thermoplastic material such as paraffin, it solidifies when cooled below a certain temperature and melts when heat is applied from the outside to raise the temperature above a certain temperature. Accordingly, by solidifying a thermoplastic material having a melting point lower than that of the reaction chamber (200) so that the solidified portion becomes an obstacle that blocks at least one of the inlet flow path (221) and the outlet flow path (222), and then heating and melting the thermoplastic material just before the diagnosis begins to make it flowable, it becomes possible to retract the solidified portion from the inlet flow path (221) and the outlet flow path (222) to open the flow path.For this purpose, for example, in a preferred embodiment of the present invention, the reaction chamber section (200) may further comprise an inlet (241) capable of injecting a thermoplastic material (240) from the outside and a sealed passage (223) having one end connected to the inlet (241) and the other end communicating with an inlet passage (221) and an outlet passage (222). In the example illustrated in FIG. 5, the reaction chamber section (200) comprises three chambers (210a, 210b, 210c), and thus, the inlet passage (221) branches into a branch that fluidly communicates with each of the three chambers (210a, 210b, 210c) at a branching point along the way. Meanwhile, the other end of the sealed channel (223) may be branched into a first sealed channel (223a) and a second sealed channel (223b), each connected to a branching point where the inlet channel (221) branches into a plurality of chambers (210a, 210b, 210c) and the other end of the outlet channel (222). In this case, it is possible to seal the inlet channel (221) and the outlet channel (222) connected to the first sealed channel (223a) and the second sealed channel (223b) by injecting a liquid thermoplastic material (240) through the inlet port (241) of the reaction chamber (200) to cool and solidify the liquid thermoplastic material (240). Then, when the thermoplastic material (240) in the sealed channel (223) is heated using the heating part of the temperature control module (6) immediately before the diagnosis begins, the thermoplastic material (240) melts again and becomes a liquid. In this state, if a pressure difference is formed between the inlet channel (221) and the outlet channel (222) through the negative pressure generating device (250), the liquid thermoplastic material (240) in the sealed channel (223) is sucked toward the outlet (230), thereby making the inlet channel (221), the sealed channel (223), and the outlet channel (222) interconnected.

[0159] Meanwhile, as described above, the compartment (110e) in the cartridge body (100) where the final processing is performed communicates with the chambers (210a, 210b, 210c) within the reaction chamber (200) through the inlet passage (221). At this time, the cartridge body (100) and the reaction chamber (200) can be injection molded such that the bottom surface of the cartridge body (100) where the compartment (110e) is formed and the bottom surface of the reaction chamber (200) where the inlet passage (221) is formed are on the same plane. In this case, as shown in FIG. 6b, the bottom surface of the internal space of the compartment (110e) is on the same plane as the bottom surface of the internal space of the inlet passage (221). Therefore, a flow path connecting the chambers (210a, 210b, 210c) within the compartment (110e) and the reaction chamber (200) can be easily formed simply by injection molding the cartridge body (100) and the reaction chamber (200) so that the concave portion forming the inlet flow path (221) communicates with the internal space of the compartment (110e). Thus, the effect of easily forming a flow path with a simple structure can be achieved while eliminating the possibility of fluid leakage, including biological samples, through the gap between the cartridge body (100) and the reaction chamber (200). Meanwhile, as described above, since the bottom surface of the cartridge main body (100) in which the compartment (110e) is formed and the bottom surface of the reaction chamber (200) in which the inlet flow path (221) is formed are formed on the same plane, as illustrated in FIG. 6b, the reaction chamber lower cover (202) covering the back surface of the reaction chamber (200) can be extended to the bottom surface of the cartridge main body (100) in which the compartment (110e) is formed, so that the bottom surface of the compartment (110e) is covered by the reaction chamber lower cover (202). However, the present invention is not limited to the content illustrated in FIG. 6b above, and a separate cover capable of covering the bottom surface of the compartment (110e) may be provided.Additionally, in the example illustrated in FIGS. 1 to 2c and FIGS. 6a and 6b, when viewed from the side, a step is formed between the compartment (110e) and the remaining compartments (110a to 110d) excluding the compartment (110e). In this case, the bottom portion of the cartridge body (100) where the compartments (110a to 110d) are installed is mounted on the stage (2) of the analysis device, while the reaction chamber portion (200) can be seated on the temperature control module (6), etc. However, the present invention is not limited to the above-described embodiment, and injection molding may be performed so that the entire bottom portion of the cartridge body (100) is on the same plane as the entire bottom portion of the reaction chamber portion (200). In this case, the bottom portion of the cartridge body (100) and the bottom portion of the reaction chamber portion (200) can be covered simultaneously using a single cover member.

[0160] Hereinafter, a preferred embodiment of a diagnostic cartridge (1) comprising a reaction chamber portion (200) equipped with chambers (211a, 211b, 211c) will be described with reference to the attached FIGS. 7 and 8.

[0161] FIG. 7 is an enlarged perspective view showing the configuration of a reaction chamber portion according to a preferred embodiment of the present invention, and FIG. 8 is an enlarged perspective view of the chamber portion of the reaction chamber portion shown in FIG. 7.

[0162] The chambers (211a, 211b, 211c) of the reaction chamber section (200) according to the embodiment shown in FIGS. 7 and 8 are injection-molded so as to protrude downward from the lower surface of the plate-shaped reaction chamber section (200), and thus the bottom surface of the chambers (211a, 211b, 211c) is located lower than the lower surface of the reaction chamber section (200), in that respect, the chambers (210, 210a, 210b, 220c) of the reaction chamber section (200) shown in FIGS. 3 and 4 are different from the chambers (210, 210a, 210b, 220c) of the reaction chamber section (200) shown in FIGS. 4.

[0163] In the case where the reaction chamber (200) is formed by penetrating the reaction chamber (200) in the vertical direction, such as the chambers (210a, 210b, 210c) of the reaction chamber (200) according to the embodiment shown in FIGS. 3 and 4, the bottom surface of the chambers (210a, 210b, 210c) exists on the same plane as the bottom surface of the reaction chamber (200), as shown in FIGS. 4 and 6b, etc. Therefore, in order to maintain a sufficient amount of reaction liquid (10) in the chamber for the reaction, there may be cases where the reaction liquid (10) is supplied into the chamber such that the surface of the reaction liquid (10) is almost equal to the top surface of the reaction chamber (200). In this case, the reaction liquid (10) inside the chamber (210a, 210b, 210c) may expand during the heating process and leak out through the outlet channel (222) or the inlet channel (221) through the channel (220) communicating with the chamber (210a, 210b, 210c) before a sufficient reaction is carried out.

[0164] Meanwhile, according to the present invention, since the bottom surface of the chamber (211a, 211b, 211c) is located lower than the bottom surface of the reaction chamber (200), even when supplying a sufficient amount of reaction liquid (10) into the chamber (211a, 211b, 211c) for the reaction, the surface of the reaction liquid (10) can be kept significantly lower than the top surface of the reaction chamber (200), as shown in FIG. 7. Therefore, even when the reaction liquid (10) is heated and expanded within the chamber (211a, 211b, 211c), the expanded reaction liquid (10) does not rise to the bottom surface of the adjacent flow path (220), so that the outflow of the reaction liquid (10) through the flow path (220) can be effectively suppressed.

[0165] Additionally, as shown in FIGS. 7 and 8, when injection molding is completed, the chambers (211a, 211b, 211c) have a hollow tubular shape with their upper and lower ends open. Therefore, it is preferable to provide a separate lower cover to cover the open lower end of the chambers (211a, 211b, 211c). In this case, the lower cover may be formed as a film-shaped member to facilitate heat transfer and ultrasonic transmission into the chambers (211a, 211b, 211c).

[0166] According to a preferred embodiment of the present invention described above, the chambers (211a, 211b, 211c) can be formed by injection molding in a shape where the upper and lower ends of the chambers (211a, 211b, 211c) are open, thereby allowing the chambers (211a, 211b, 211c) to have a shape that is easy to inject, and the bottom portion of the chambers (211a, 211b, 211c) can be easily formed by attaching a cover to the open lower surface after injection molding.

[0167] And, the open upper portion of the chamber (211a, 211b, 211c) can be covered by a reaction chamber upper cover (201) that covers the entire upper surface of the reaction chamber portion (200), as in the embodiment shown in FIG. 6b.

[0168] Hereinafter, a preferred embodiment of a diagnostic cartridge (1) equipped with a valve (260) for opening and closing an inlet passage (221) will be described with reference to the attached FIG. 9.

[0169] FIG. 9 is an enlarged perspective view of a portion of a diagnostic cartridge with a valve installed according to a preferred embodiment of the present invention.

[0170] The embodiment illustrated in FIG. 9 is different from the embodiment illustrated in FIG. 1 and FIG. 7 in that it is equipped with a valve (260) capable of opening and closing the inlet passage (221) in the middle of an inlet passage (221) in which one end is fluidly connected to a compartment (110e) of the cartridge body part (100) and the other end is fluidly connected to a chamber (211a, 211b, 211c).

[0171] In the embodiment illustrated in FIG. 1 or FIG. 7, the inlet channel (221) is in constant fluid communication with the compartment (110e) of the cartridge body (100). Therefore, if a portion of the reaction liquid (10) in the chamber (210) evaporates, there is a concern that moisture from the evaporated reaction liquid (10) may be transferred to the freeze-dried reagent in the compartment (110e) through the inlet channel (221).

[0172] However, according to the present invention, the inlet passage (221) between the compartment (110e) within the cartridge body (100) and the chambers (211a, 211b, 211c) of the reaction chamber (200) can be selectively opened and closed through the valve (260). Accordingly, before using the diagnostic cartridge (1), the inlet passage (221) between the compartment (110e) within the cartridge body (100) and the chambers (211a, 211b, 211c) of the reaction chamber (200) can be closed through the valve (260), thereby effectively preventing moisture from the reaction chamber (200) from being transferred to the freeze-dried reagent. Then, when the biological sample that has undergone the final processing in the compartment (110e) is supplied to the chambers (211a, 211b, 221c) of the reaction chamber section (200) through the flow path (220), the valve (260) is opened, and when the supply of the biological sample is completed, the valve (260) is closed again. By doing so, the leakage of the reagent evaporated during the reagent amplification process in the reaction chamber section (200) to the cartridge main body section (100) through the inlet flow path (221) can be effectively suppressed.

[0173] Meanwhile, in the embodiment illustrated in FIG. 9, the valve (260) may be provided with a valve seat (261) that opens and closes the inside of the inlet passage (221) by moving back and forth toward the inlet passage (221), a piston part (262) extending in an upward and downward direction from the valve seat (261), and a piston head (263) provided at the end of the piston part (262) facing the valve seat (261). Here, a portion of the valve seat (261) and the piston part (262) extends to the side of the inlet passage (221) through the cartridge body part (100), and a portion of the piston head (263) and the end of the piston part (262) to which the piston head (263) is attached is exposed to the outside of the cartridge body part (100). The user can open the inlet passage (221) by grasping the externally exposed piston head (263) and pulling the piston part (262) connected to the piston head (263) upward, thereby moving the valve seat (261) away from the inlet passage (221). Additionally, the user can close the inlet passage (221) by grasping the externally exposed piston head (263) and pushing the piston part (262) connected to the piston head (263) downward, thereby moving the valve seat (261) into the inlet passage (221).

[0174] According to the present invention, by operating the piston head (263) of the valve (260) from the outside of the diagnostic cartridge (1), the opening and closing of the inlet passage (221) between the compartment (110e) and the reaction chamber (200) within the cartridge body (200) inside the diagnostic cartridge (1) can be effectively controlled. However, the valve (260) of the present invention is not limited to the piston-type valve shown in FIG. 9. For example, the valve (260) may be an electronically controlled electric ball valve.

[0175] Meanwhile, referring to the illustration in FIG. 9, the reaction chamber section (200) is provided with a plurality of chambers (211a, 211b, 211c), and the inlet passage (221) may be composed of a plurality of inlet passages connected to each of the compartment (110e) of the cartridge main body section (100) and the plurality of chambers (211a, 211b, 211c). At this time, each of the plurality of inlet passages (221) may include a first inlet passage (221a) with one end connected to the compartment (110e), a second inlet passage (221c) located above the first inlet passage (221a) when viewed from the side and with one end connected to the chamber (211a, 211b, 211c), and a third inlet passage (221b) extending upward from the other end of the first inlet passage (221a) to the other end of the second inlet passage (221c). Here, it is preferable that the first inlet passage (221a) and the second inlet passage (221c) extend horizontally, but the embodiment of the present invention is not limited to the extension direction described above. That is, when viewed from the side, the first inlet passage (221a) and the second inlet passage (221c) may extend relatively horizontally (i.e., extend with a small angle of inclination) in contrast to the third inlet passage (22b) connecting the two. Additionally, in FIG. 9, the third inlet channel (221b) extends in a vertical direction, but embodiments of the present invention are not limited to the above-mentioned illustration. The third inlet channel (221b) may extend upward to have a relatively larger angle of inclination than the first inlet channel (221a) and the second inlet channel (221c) when viewed from the side.

[0176] According to the above embodiment, the final purified sample (11) contained in the compartment (110e) is introduced into each chamber (211a, 211b, 211c) in the order of the first inlet passage (221a), the third inlet passage (221b), and the second inlet passage (221b) of the plurality of inlet passages (221).

[0177] However, as illustrated in FIG. 9, when viewed from the side, the second inlet channel (221c) is located above the first inlet channel (221a), and the third inlet channel (221b) connecting the first inlet channel (221a) and the second inlet channel (221c) has a shape that extends from the bottom upward. Accordingly, the reagent (11) passing through each inlet channel (221) moves through the relatively horizontal first inlet channel (221a), then rises along the third inlet channel (221b) that extends in the vertical direction, and then moves through the relatively horizontal second inlet channel (221c) to reach each chamber (211a, 211b, 211c).

[0178] Meanwhile, when the piston (251) of the negative pressure generating device (250) is pulled upward to generate negative pressure, if there is a fine structural difference between the multiple inlet passages, a finely different negative pressure is applied to each inlet passage. Therefore, if the inlet passage (221) does not have the above-mentioned structure and has a structure that extends only in a horizontal direction as shown in FIG. 3, etc., the reagent (11) may be filled first in a specific chamber connected to a specific passage where a relatively strong negative pressure is applied. As a result, uneven distribution of the reagent may occur in the multiple chambers (211a, 211b, 211c). If the reagent is unevenly distributed in each chamber, the reaction results in each chamber may also be uneven.

[0179] In contrast, according to a preferred embodiment of the present invention, nearly equal amounts of sample can be supplied to each chamber (211a, 211b, 211c). Thus, more accurate reagent distribution can be achieved, thereby further increasing the accuracy of the reaction. FIG. 10 shows the results of testing the reagent supply status through each flow path when reagents (11a, 11b, 11c) are supplied to each chamber (211a, 211b, 211c) respectively using the diagnostic cartridge according to the preferred embodiment of the present invention shown in FIG. 9.

[0180] As illustrated in FIG. 10, a reagent (11c) passing through a specific channel receiving a slightly stronger negative pressure among a plurality of channels passes through the first inlet channel (221a) (Fig. 10 (b)). It rises first within the third inlet channel (221b) (Fig. 10 (c)). However, the sample (11c) that first reaches and fills the third inlet channel (221b) receives relatively less force within the third inlet channel (221b) which extends in the vertical direction. Meanwhile, samples (11a, 11b) that rise later within the third inlet channel (221b) through channels receiving relatively weaker negative pressure receive relatively greater force within the third inlet channel (221b) which extends in the vertical direction. As a result, the samples (11a, 11b, 11c) arrive at the point where the third inlet channel (221b) ends and the relatively horizontal second inlet channel begins (Fig. 10 (d)) almost simultaneously.

[0181] Accordingly, reagents (11a, 11b, 11c) passing through a plurality of inlet passages connecting the compartment (110e) and each chamber (211a, 211b, 211c) can reach each chamber (211a, 211b, 211c) almost simultaneously (e of FIG. 10), so that an equal amount of reagents (11a, 11b, 11c) can be supplied to each chamber (211a, 211b, 211c).

[0182] Hereinafter, with reference to the attached drawings, a preferred embodiment of a diagnostic cartridge (1) is described, which further includes a reagent supply unit (300) for supplying a reagent into the compartments (110a, 110b, 110c, 110d, 110e) of the cartridge body (100).

[0183] FIG. 11 is an exploded perspective view showing the reagent supply unit and piston unit of a diagnostic cartridge according to a preferred embodiment of the present invention in a detached state, and FIG. 12 is a perspective view showing the reagent supply unit and piston unit shown in FIG. 11 assembled to the cartridge body. FIG. 13a is a side view showing the state before the reagent supply unit shown in FIG. 11 is assembled to the cartridge body, and FIG. 13b is a side view showing the state after the reagent supply unit is assembled to the cartridge body.

[0184] As illustrated in FIG. 11, a preferred embodiment of the present invention further includes a reagent supply unit (300) for supplying a reagent into the compartments (110a, 110b, 110c, 110d, 110e) of the cartridge body (100).

[0185] Preferably, the reagent supply unit (100) may be formed in a tubular shape with an open bottom and a ceiling portion covering the top, opposite to the cartridge body portion (100). In order to maintain the accuracy of the analysis and the consistency of the analysis results when analyzing using a diagnostic cartridge, it is important to ensure that the fluid used for the analysis is not exposed to the outside before and during the analysis. Therefore, in a preferred embodiment of the present invention, the reagent is stored in a sealed space within the reagent chamber (310) of the reagent supply unit (300) before the analysis is performed. And, when performing analysis using the diagnostic cartridge (1), the reagent is supplied from the reagent supply unit (100) into the compartments (110a, 110b, 110c, 110d, 110e) within the cartridge body (100) through the process of combining the reagent supply unit (300) and the cartridge body (100), and in the state where the combination is completed, the reagent supply unit (300) covers the open upper part of the cartridge body (100) from the top to form a sealed space between the reagent supply unit (100) and the cartridge body (100).

[0186] FIG. 14 is a perspective view of the upper surface of the reagent supply unit shown in FIG. 11 facing upward, and FIG. 15 is a perspective view of the lower surface of the reagent supply unit shown in FIG. 11 facing upward. Based on the details shown in FIG. 14 and FIG. 15, the specific configuration of the reagent supply unit (100) is described as follows. For convenience of explanation, the sealing film (312) covering the upper surface of each of the plurality of reagent chambers (310) of the reagent supply unit (100) is omitted in FIG. 14 and FIG. 15.

[0187] As shown in FIG. 14, the reagent supply unit (300) has a sample inlet (301) formed on one side of its ceiling and a sample outlet (303) formed on the other side.

[0188] The sample inlet (301) is an opening for injecting a sample to be analyzed, and the sample inlet (301) is positioned on the reagent supply unit (300) so as to be delivered to a corresponding compartment (110a) of the cartridge body (100) through one of the multiple reagent chambers (310) within the reagent supply unit (300). Meanwhile, to prevent the injected sample from leaking out and to prevent the sealed space between the reagent supply unit (300) and the cartridge body (100) from coming into contact with the outside, the sample inlet (301) may be provided with an openable sample inlet cover (302). The user can insert a sample into the diagnostic cartridge (1) through the sample inlet (301) while the sample inlet cover (302) is open, and then close the sample inlet (301) using the sample inlet cover (302).

[0189] Meanwhile, the sample outlet (302) is an opening for discharging a purified sample to the outside after processing in a plurality of compartments (110a, 110b, 110c, 110d, 110e) within the diagnostic cartridge (1), and is equipped with a sample outlet cover (304) that can open and close the sample outlet (302), just like the sample inlet (301). Generally, in the case of cartridges for POCT (Point of Care Testing) testing equipment developed in the past, since they are intended for single use, it was not possible to discharge the purified sample obtained through processing within the cartridge to the outside. Therefore, if the POCT test failed, the purified sample (nucleic acid) could not be reused, and there was a problem that the sample had to be collected again from the subject. However, according to the present invention, a sample outlet (302) is provided in the reagent supply unit (300) to allow access to the compartment (110e) where the last processing was performed within the cartridge main body (100). Accordingly, if the POCT test fails, the user can open the sample discharge port cover (304) and insert a pipette or the like into the compartment (110e) through the sample discharge port (302) to collect a purified sample from the compartment (110e). Therefore, if the POCT test fails, the purified sample remaining in the compartment (110e) can be reused to proceed with the analysis again, thus eliminating the need to collect a sample (specimen) from the subject as in the prior art. Meanwhile, in FIG. 14, a sample discharge port (302) is formed at a location corresponding to the compartment (110e) closest to the reaction chamber (200) (the compartment where the last processing was performed), but the present invention is not limited to the above-described embodiment; that is, multiple sample discharge ports may be formed to discharge the sample being processed from each of the multiple compartments by forming multiple through holes at locations on the sample supply unit corresponding to the multiple compartments.

[0190] A reagent supply unit (300) according to a preferred embodiment of the present invention comprises a plurality of reagent chambers (310a, 310b, 310c, 310d, 310e) for storing a reagent (11) inside the cylindrical shape of the reagent supply unit (300). As shown in FIGS. 14 and 15, the plurality of reagent chambers (310a, 310b, 310c, 310d, 310e) have a hollow cylindrical shape surrounded by reagent chamber walls (311a, 311b, 311c, 311d). Each of the plurality of reagent chambers (310a, 310b, 310c, 310d, 310e) may contain a wash solution for washing a sample or an elution solution for nucleic acid extraction. The reagent chamber walls (311a, 311b, 311c, 311d) constituting each of the plurality of reagent chambers (310a, 310b, 310c, 310d, 310e) are composed of two pairs of walls arranged facing each other to have a rectangular cross-section when viewed from above, but the present invention is not limited to the above-described embodiment. For example, each of the reagent chambers (310a, 310b, 310c, 310d, 310e) may have a cylindrical shape in which the outer surface and / or inner surface formed by the reagent chamber walls is circular when viewed from above. Meanwhile, a sealing film (312) for covering the open bottom surface of each reagent chamber (310a, 310b, 310c, 310d, 310e) is attached to the bottom surface of the reagent chamber wall portions (311a, 311b, 311c, 311d) of each reagent chamber (310a, 310b, 310c, 310d, 310e). As described below, the sealing film (312) is perforated by the perforation (130) of the cartridge body (100) during the process of combining the reagent supply unit (300) with the cartridge body (100), and as a result, the reagent (11) is transferred from the reagent chambers (310a, 310b, 310c, 310d, 310e) to the compartments (110a, 110b, 110c, 110d, 110e) corresponding to each reagent chamber.Meanwhile, the reagent chamber walls (311a, 311b, 311c, 311d) constituting each of the reagent chambers (310a, 310b, 310c, 310d, 310e) may have a shape that slopes from one side toward the other when viewed from one side. For example, in the example illustrated in FIG. 15, the heights of a pair of walls (311b, 311a) facing each other in the width direction of the reagent supply section (300) among the reagent chamber walls (311a) are configured differently, so that another pair of walls (311c, 311d) extending between the pair of walls (311b, 311a) form a sloped section. According to the above configuration, as described below, when the perforation portion (130) comes into contact with the sealing film (312) provided in the reagent chamber (310a, 310b, 310c, 310d, 310e), the perforation portion (130) comes into contact sequentially starting from the portion adjacent to the long wall portion (311b) of the sealing film (312). Therefore, compared to the case where the perforation portion (130) comes into contact with the entire surface of the sealing film (312) at once, a perforation can be formed more easily in the sealing film (312).

[0191] Meanwhile, as described above, the cartridge main body (100) is provided with a plurality of perforations (130) such that, in the process of combining with the reagent supply unit (300), a perforation is formed in the sealing film (312), allowing the reagent (11) contained in the reagent chambers (310a, 310b, 310c, 310d, 310e) of the reagent supply unit (300) to fall into each of the plurality of compartments (110) of the cartridge main body (100) by its own weight and be contained within the compartments (110).

[0192] In this regard, FIG. 16 is a broken perspective view showing the state before the cartridge body and reagent supply unit shown in FIG. 11 are combined, and FIG. 17 is a broken perspective view showing the state after the combination of the cartridge body and reagent supply unit shown in FIG. 11 is completed.

[0193] As illustrated in FIGS. 11, 16, and 17, a hollow perforated section (130) surrounded by perforated wall sections (131a, 131b, 131c, 131d) is provided above each compartment (110) of the cartridge body (100). That is, in the embodiment illustrated in FIGS. 11, 16, and 17, the perforated section (130) has an outer surface that has a rectangular cross-section when viewed from above, similar to the inner surface of the hollow of a plurality of reagent chambers (310a, 310b, 310c, 310d, 310e). However, the present invention is not limited to the above-described embodiment. For example, when each reagent chamber (310a, 310b, 310c, 310d, 310e) has a cylindrical shape with a circular inner surface, each of the plurality of perforations (130) may have a cylindrical shape with a circular outer surface. And, preferably, in any one of the perforation wall parts (131a, 131b, 131c, 131d), a reagent supply port (133) in the form of an opening that connects the longitudinal hole in the perforation (130) with the internal space of the compartment (110) so that the reagent (11) that has fallen into the hollow of the perforation (130) can flow into the compartment (110).

[0194] As described above, since the perforation portion (130) has a hollow shape surrounded by perforation portion walls (131a, 131b, 131c, 131d), when it penetrates the sealing film (312) and enters each reagent chamber (310a, 310b, 310c, 310d, 310e), it can come into contact with the sealing film (312) over the entire circumference of the perforation portion walls (131a, 131b, 131c, 131d) constituting the perforation portion (130). Accordingly, a perforation of sufficient size can be effectively formed so that the entire amount of reagent (11) contained in each reagent chamber (310a, 310b, 310c, 310d, 310e) can fall into the compartment (110a, 110b, 110c, 110d, 110e) through the perforated hole in the sealing film (312) by the weight of the reagent (11).

[0195] Meanwhile, as in the embodiment of the present invention described above, when viewed from above, the shape of the inner surface of the reagent chamber (310a, 310b, 310c, 310d, 310e) and the shape of the outer surface of the perforation (130) do not necessarily have to be identical in corresponding shapes, but if the shape of the inner surface of the reagent chamber (310a, 310b, 310c, 310d, 310e) and the shape of the outer surface of the perforation (130) have corresponding shapes, the perforation can be formed more effectively and the entire amount of reagent (11) can be induced to fall into the hollow within the perforation (130). Accordingly, it is desirable that the trajectory formed by the outer surface of the perforation (130) when viewed from above almost coincides with the trajectory formed by the inner surface of each reagent chamber (310a, 310b, 310c, 310d, 310e) to the extent that the perforation (130) can enter the reagent chamber (310a, 310b, 310c, 310d, 310e). Also, in order to prevent the reagent from leaking out of the perforation (130) during the perforation process, it is desirable that the area formed by the outer surface of the perforation (130) when viewed from above be at least 90%, preferably at least 95%, of the area formed by the inner surface of the reagent chamber (310a, 310b, 310c, 310d, 310e).

[0196] Meanwhile, as illustrated in FIGS. 16 and 17, preferably, the perforation portion (130) may further be provided with an inclined portion (132) that extends downwardly at an angle, with one end connected to one of the wall portions (131a, 131b, 131c, 131d) of the perforation portion (130) and the other end connected to a side wall (111) of the compartment (110). In this case, when the sealing film (312) is perforated by the perforation part (130), the reagent (11) is introduced from the reagent chamber (310a, 310b, 310c, 310d, 310e) into the hollow interior of the perforation part (130), and the introduced reagent (11) flows down along the inclined part (132) and is guided through the reagent supply port (133) to the compartment (110) located on the front lower side of the perforation part (130).

[0197] Meanwhile, as described above, the cartridge body (100) is injection molded so that the lower part of the compartment (110) is open. At this time, if the side wall (111) of the compartment (110) connected to the inclined part (132) overlaps with the wall part (131a) of the perforation part (130) located above the side wall (111) when viewed from above, an undercut may occur during injection molding, making injection molding difficult. Accordingly, as illustrated in FIG. 16, it is preferable to configure the side wall (111) of the compartment (110) connected to the inclined portion (132) so that when viewed from above, the side wall (111) is offset from the wall portion (131a) of the perforation portion (130) located above the side wall (111), for example, so that the side wall (111) is positioned further inward toward the perforation portion (130) than the wall portion (131a) of the perforation portion (130). Through the above configuration, a structure that is transmitted from the perforation portion (130) to the compartment (110) through the inclined portion (132) without the occurrence of an undercut can be realized by injection molding.

[0198] The process of the reagent (11) flowing into the compartment (110) from the reagent chamber (310) of the reagent supply unit (300) through the perforation (130) is illustrated in FIGS. 16 to 18b.

[0199] When the user pushes the reagent supply unit (300), which is filled with reagent (11) in the reagent chamber (310) and sealed with a sealing film (312), toward the cartridge body (100), the reagent supply unit (300) descends, and some of the perforation side walls (131a, 131b, 131c, 131d) of the perforation unit (130) begin to come into contact with the sealing film (312) around the nearest wall (311b) of the reagent chamber wall (311a, 311b, 311c, 311d) of the reagent chamber (310). In this state, if the user applies more force and presses the reagent supply unit (300) toward the cartridge body (100), a rupture occurs starting from the portion of the sealing film (312) around the reagent chamber wall (311b), and the ruptured portion propagates along the periphery of the remaining perforation side walls (131b, 131c, 131d) of the perforation unit (130), and finally, the sealing film (312) is torn around the entire outer circumference of the perforation side walls (131a, 131b, 131c, 131d). As a result, the entire amount of reagent (11) contained in the reagent chamber (310) falls downward due to its own weight and flows into the hollow space within the perforation unit (130). And the reagent (11) introduced into the hollow space within the perforation section (130) is introduced into the compartment (110) through the reagent supply port (133) formed in the wall section (131) of the perforation section along the inclined section (132).

[0200] Hereinafter, a preferred embodiment of a diagnostic cartridge (1) including a perforation portion (130) having an edge portion (140) will be described with reference to the attached FIGS. 19a to 19d.

[0201] FIG. 19a is a broken perspective view showing the internal structure of a diagnostic cartridge according to a preferred embodiment of the present invention, FIG. 19b is a partial perspective view showing an enlarged perforation portion of the diagnostic cartridge shown in FIG. 19a, FIG. 19c is a cross-sectional view showing the state in which the cartridge body portion and the reagent supply portion of the diagnostic cartridge shown in FIG. 19a are assembled, and FIG. 19d is a drawing for explaining the flow of reagent in the state shown in FIG. 19a.

[0202] The embodiment illustrated in FIG. 19a to 19d is different from the embodiment illustrated in FIG. 11 in that an edge portion (140) is formed on the upper surface of the wall portions (131a, 131b, 131c, 131d) of the hollow perforation portion (130) of the cartridge body portion (100), with a pointed portion (140a) protruding toward the sealing film (312) of the reagent chamber (311a).

[0203] According to the embodiment of the present invention described above, unlike other embodiments described previously, the upper surface of the perforation portion (130) has a sharp blade structure, so the perforation portion (130) can effectively cut the sealing film (312) of the reagent chamber (310) during the process of combining the reagent supply portion (300) and the cartridge body portion (100).

[0204] Meanwhile, as illustrated in FIG. 19b, the pointed portion (140a) of the edge portion (140) may be formed along the perimeter of the wall portions (131a, 131b, 131c, 131d) of the hollow perforation portion (130) when viewed from above. In this case, the pointed portion (140a) of the edge portion (140) may be made to come into contact with the sealing film (312) along the corresponding entire perimeter of the sealing film (312) of the reagent chamber (310), thereby allowing the sealing film (312) to be cut more effectively.

[0205] Additionally, as shown in FIGS. 19b to 19d, the edge portion (140) may have an inclined portion (140b) formed to slope downward from the pointed portion (140a) toward the interior of the hollow of the perforation portion (130).

[0206] In this case, as illustrated in FIG. 19c, the reagent supply unit (300) and the cartridge body unit (100) are combined, so that when the sealing film (312) of the reagent chamber (310) is cut by the blade structure of the edge unit (140) and the reagent (11) stored in the reagent chamber (310) falls toward the compartment (110) of the cartridge body unit (100), the reagent (11) can be effectively guided to flow into the hollow within the perforation unit (130) through the inclined unit (140b).

[0207] Hereinafter, a diagnostic cartridge (1) according to another preferred embodiment including a perforation portion (130) having an edge portion (140) will be described with reference to the attached FIGS. 20 to 22.

[0208] FIG. 20 is an exploded perspective view of a diagnostic cartridge according to another preferred embodiment of the present invention, FIG. 21 is a broken perspective view for illustrating the interior of the cartridge body portion of the diagnostic cartridge shown in FIG. 20, and FIG. 22 is a cross-sectional view showing the state in which the cartridge body portion and the reagent supply portion of the diagnostic cartridge shown in FIG. 21 are assembled.

[0209] As illustrated in FIGS. 20 to 22, the perforation portion according to the embodiment illustrated in FIGS. 20 to 22 is different from the embodiment illustrated in FIGS. 19a to 19d in that the lower surface facing the perforation portion (130) of each compartment (310) of the reagent supply portion (300) is formed flat, and the heights of a pair of opposing wall portions (131a, 131b) among the wall portions (131a, 131b, 131c, 131d) of the hollow perforation portion (130) are configured differently so that another pair of wall portions (131c, 131d) extending between the pair of wall portions (131a, 131b) form an inclined portion, and an edge portion (140) is not formed on the upper surface of some wall portions (131a). Meanwhile, in order to illustrate the configuration of the perforation section (130) more clearly, the illustration of the compartment (110) of the cartridge main body (100) located in front of the perforation section (130) and the compartment wall (111) constituting the compartment (110) is omitted in FIG. 21.

[0210] As illustrated in FIGS. 20 and 21, when the heights of some of the wall portions (131a, 131b, 131c, 131d) of the perforation portion (130) are varied, the edge portion (141a) formed on the wall portion (131b) with the highest height first comes into contact with the sealing film (312) of the reagent chamber (310) and cuts the contact portion of the sealing film (312). Then, the sealing film (312) is cut sequentially along the edge portions (141b, 141c) formed on the wall portions (131c, 131d) that form inclined surfaces. Accordingly, according to the present invention, it is possible to limit the cutting direction, range, and order when the sealing film (312) of the reagent chamber (310) is cut by the edge portion (140) formed on the upper surface of the perforation portion (130). In addition, the area of ​​force received by the sealing film (312) can be reduced so that the sealing film (312) can be cut with less force. Thus, the cartridge body (100) and the reagent supply unit (300) can be joined more smoothly.

[0211] Meanwhile, in the embodiment according to the present invention illustrated in FIGS. 20 to 22, the edge portion (140) is not formed on some of the wall portions (131a, 131b, 131c, 131d) constituting the hollow perforation portion (130), particularly on the wall portion (131a) which is relatively lower in height among a pair of wall portions (131a, 131b) which have different heights from each other.

[0212] According to the present invention described above, when the sealing film (312) is cut while the reagent supply unit (3100) and the cartridge body unit (100) are combined, it is possible to control so that only a specific part of the sealing film (312) corresponding to the wall (131a) of the perforation unit (130) where the edge portion (140) is not formed is not cut. In this case, as shown in FIG. 22, a part of the sealing film (312) that is not cut climbs up the wall surface of the reagent chamber wall (311a) facing the wall (131a) of the perforation unit (130) where the edge portion (140) is not formed, and is located in the space between the wall (131a) of the perforation unit (130) and the reagent chamber wall (311a). Accordingly, according to an embodiment of the present invention, as shown in FIG. 22, it is possible to prevent a portion of the cut sealing film (312) from being located within the path through which the reagent (11) in the reagent chamber (310) falls into the hollow of the perforation (130). Accordingly, according to the present invention, by unevenly cutting the sealing film (312) by the perforation (130), it is possible to effectively prevent a portion of the sealing film (312) from blocking the falling of the reagent (11). However, in order to obtain the above-mentioned effect more reliably, it is preferable that the vertical length of the space between the wall (131a) of the perforation (130) and the reagent chamber wall (311a) be longer than the length of the sealing film (312) extending between the reagent chamber walls, so that the sealing film (312) can be pushed up more reliably into the space between the wall (131a) of the perforation (130) and the reagent chamber wall (311a).

[0213] Hereinafter, a diagnostic cartridge (1) according to another preferred embodiment comprising a perforation portion (130) having an edge portion (140) will be described with reference to the attached FIGS. 23 to 24b.

[0214] FIG. 23 is a drawing for showing the cross-sectional shape of the edge portion formed in the perforation portion shown in FIG. 21, and FIG. 24a and FIG. 24b are drawings for explaining the difference in the positioning effect of the reagent chamber depending on the presence or absence of the inclined surface of the edge portion shown in FIG. 23.

[0215] The embodiment illustrated in FIGS. 23 to 24b is different from the embodiment illustrated in FIGS. 19a to 19d in that, among the plurality of edge portions formed on each wall portion constituting the perforation portion (130), at least some edge portions (141b, 141c) further comprise an inclined portion (142a) formed downwardly inclined from the pointed portion (140a) toward the outside of the perforation portion (130), in addition to an inclined portion (142b) formed downwardly inclined toward the inside of the hollow of the perforation portion (130) from the pointed portion (140a).

[0216] FIG. 24a illustrates a case in which mutually opposing edge portions (141b, 141c) each have only an inclined portion (143b) facing the interior of the hollow of the perforation portion (130), and a surface (143a) facing the exterior of the hollow of the perforation portion from the edge portions (141b, 141c) extends perpendicularly to the upper surface of the perforation portion (130). In this case, as illustrated in FIG. 24a, when the cartridge body (100) and the reagent supply unit (300) are combined while there is a gap between the perforation (130) of each compartment (110) of the cartridge body (100) and the reagent chamber (310) of the reagent supply unit (300), there may be a case where the edge portions (141b, 141c) cannot enter the space between the wall portions (311b, 311c) of the reagent chamber (310).

[0217] On the other hand, according to an embodiment of the present invention, as shown in FIG. 24b, even when a gap occurs between the perforation (130) of each compartment (110) of the cartridge body (100) and the reagent chamber (310) of the reagent supply unit (300), the inner wall surface of the reagent chamber wall (311b) can be moved along the slope of the inclined portion (142a) of the edge portion (141b) so that the perforation (130) can be effectively induced to enter the reagent chamber (310).

[0218] Meanwhile, as illustrated in FIG. 23, according to another preferred embodiment of the present invention, the pointed portion (140a) of the edge portion (140) may have at least one sawtooth-shaped protrusion (140c) protruding toward the sealing film (312) of the reagent chamber (310).

[0219] According to the above-described embodiment of the present invention, the reagent supply unit (300) and the cartridge body unit (100) are combined, so that when the sealing film (312) of the reagent chamber (310) is cut by the edge unit (140), a through hole can first be formed in the sealing film (312) of the reagent chamber (310) using the sawtooth-shaped protrusion (140c). In this case, the sealing film (312) can be effectively cut by continuously cutting the through hole along the pointed portion (140a).

[0220] FIG. 23 illustrates having one sawtooth-shaped protrusion (140c), but the present invention is not limited to the example described above. For instance, it may be formed continuously along the entire tip portion (140a) of the edge portion (140). Also, in the example illustrated in FIG. 23, the shape of the sawtooth-shaped protrusion (140c) is triangular, but the present invention is not limited to the example described above. The sawtooth-shaped protrusion (140c) may be rectangular as long as it has a shape that can effectively penetrate the sealing film (312).

[0221] FIGS. 25a to 25c are drawings illustrating the flow of a reagent from the cartridge body to the reaction chamber according to the piston operation of the negative pressure generating device (syringe) illustrated in FIG. 11. Referring to FIGS. 25a to 25c, the process of moving the reagent from the cartridge body (100) to the reaction chamber (200) is set as follows.

[0222] In the case of the negative pressure generating device (250) illustrated in FIGS. 25a to 25c, a pressure difference is generated between the inlet passage (221) and the outlet passage (222) within the reaction chamber (200) by gripping and extending the piston head (252) of the piston (251) inserted inside. Specifically, in the state illustrated in FIG. 25a, when the user or the negative pressure generating module (7) of the analysis device grips the piston head (252) of the piston (251) and pulls it upward, negative pressure is applied to the outlet (230) connecting the negative pressure generating device (250) and the reaction chamber (200), and thus a pressure difference is generated between the inlet passage (221) connected to the compartment (110e) and the outlet passage (222) connected to the negative pressure generating device (250) through the outlet (230). Due to this pressure difference, the purified sample (11) contained in the compartment (110e) is sucked into the inlet path (221). The sucked sample (11) enters the chambers (210a, 210b, 210c) and reacts with the reaction liquid (10) inside the chambers (210a, 210b, 210c).

[0223] In the examples illustrated in FIGS. 25a to 25c, a syringe equipped with a piston (251) mounted on a diagnostic cartridge (1) is illustrated as an example of a negative pressure generating device (250), but the present invention is not limited to the above-mentioned embodiments. For example, the negative pressure generating module (7) of the analysis device may be equipped with a negative pressure generating device such as a small vacuum pump, and the negative pressure may be generated within the flow path (220) by connecting this small vacuum pump to the outlet (230) of the reaction chamber (200) through a predetermined connecting hose.

[0224] Method for manufacturing a diagnostic cartridge

[0225] The aforementioned diagnostic cartridge can be manufactured in the following way.

[0226] First, a cartridge body part (100) and a reaction chamber part (200) having the shape according to the preferred embodiment described with reference to FIGS. 1 to 6a are integrally injection molded using a single mold. Next, a cartridge body part lower cover (101) is attached to the bottom part of the cartridge body part (100), and a reaction chamber part lower cover (202) or a reaction chamber part upper cover (201) is attached to the bottom part or surface part of the reaction chamber part (200). Then, in that state, a liquid thermoplastic material (240) is injected into the sealed flow path (223) of the reaction chamber part (200) through the injection port (241) of the reaction chamber part (200), and then the thermoplastic material (240) is solidified through cooling or other processing, thereby sealing at least one of the inlet flow path (221) and outlet flow path (222) of the reaction chamber part (200). Afterward, the reaction liquid (10) is supplied through the open portions of each chamber (210a, 210b, 210c) on the surface of the reaction chamber section (200) where the cover is not attached, thereby filling the inside of the chambers (210a, 210b, 210c) with the reaction liquid (10). Next, a cover is attached to the surface of the reaction chamber section (200) where the cover is not attached, thereby covering the open portions of the chambers (210a, 210b, 210c) and / or the flow path (220).

[0227] Mechanism of sample and reagent movement within the diagnostic cartridge

[0228] Hereinafter, the mechanism of movement of the sample and / or reagent within the diagnostic cartridge (1) will be explained with reference to the illustrations in FIGS. 26a to 27.

[0229] FIGS. 26a to 26c are drawings for explaining the process of transferring a reagent from the reagent supply unit shown in FIG. 7 to the cartridge body and the process of transferring a nucleic acid within the cartridge body, and FIG. 27 is a drawing for explaining a diagnostic cartridge according to a preferred embodiment of the present invention and the process of transferring a nucleic acid within the cartridge body using the same.

[0230] FIGS. 26a to 26c illustrate an embodiment in which a diagnostic cartridge (1) is provided with a separate reagent supply unit (300) to supply reagents into compartments (110a, 110b, 110c, 110d, 110e). As shown in FIGS. 26a and 26b, as a user pushes the reagent supply unit (300) toward the cartridge body (100), the perforation unit (130) forms a perforation in the sealing film (312) that seals each compartment (310) of the reagent supply unit (300), and through this perforation, the reagent (11) contained in each compartment (310) falls by its own weight and is supplied to each of the plurality of compartments (110a, 110b, 110c, 110d, 110e) inside the cartridge body (100). At this time, the internal space formed by the reagent supply unit (300) and the cartridge body (100) is sealed from the external space by the reagent supply unit (300) and the cartridge body (100). Accordingly, the reagent (11) and the sample are not exposed to the outside during the process of transferring the reagent (11) from each compartment (310) of the reagent supply unit (300) into the plurality of compartments (110a, 110b, 110c, 110d, 110e) and the subsequent processing process.

[0231] Next, as illustrated in FIG. 26b, the user opens the sample inlet cover (302) of the reagent supply unit (300) and inserts a sample (specimen) collected using a pipette or the like through the sample inlet (301) into one of the compartments (110a) of the cartridge main body (100). At this time, magnetic beads (12) are inserted into the compartment (110a) where the sample is first inserted to mix the reagent (11) and the sample well, grind the sample, and attach the components of the ground sample so that the corresponding components of the sample are moved between each compartment (110a, 110b, 110c, 110d, 110e). The magnetic bead (12) may be inserted into the compartment (110a) before combining the reagent supply unit (300) and the cartridge body (100), or inserted into the compartment (110a) through the sample inlet (301) after combining the reagent supply unit (300) and the cartridge body (100).

[0232] Next, the magnetic bead (12) is moved using a magnetic field formed by the magnetic body (14) of the magnetic bead transfer module (3) provided in the analysis device, or by moving the magnetic bead (12) using ultrasound generated by the ultrasound generation module (5) provided in the analysis device and propagated into the compartment (110a), thereby crushing the sample and destroying the cells so that the sample and the reagent (11) are well mixed. Through this process, a component containing nucleic acid (13) leaked from the cells of the sample is attached to the surface of the magnetic bead (102).

[0233] Next, when the magnetic bead transfer module (3) moves the magnetic body (14), the magnetic bead (12) moves along the side wall of the cartridge body (100) in accordance with the movement of the magnetic body (14) by the magnetic field of the magnetic body (14) transmitted through the side wall of the cartridge body (100). Using this, it is possible to move the magnetic bead (12), to which a component including nucleic acid (13) is attached, between each compartment (110a, 110b, 110c, 110d, 110e) through the upper part communicating with each compartment (110a, 110b, 110c, 110d, 110e).

[0234] Meanwhile, the reagent contained within the compartments (110a, 110b, 110c, 110d) may be, for example, a wash solution for washing foreign substances other than the detection target attached to the surface of the magnetic bead (12). In this case, the magnetic bead (12) may be moved sequentially between each compartment (110a, 110b, 110c, 110d) to perform a process of removing other foreign substances from the surface of the magnetic bead (12).

[0235] And, in the case where the diagnosis performed by the analysis device is a molecular diagnosis, the reagent (11) contained inside the compartment (110e) where the final treatment is performed may be an elution solution for nucleic acid extraction. As the magnetic bead (12) moves into the compartment (110e) where the final treatment is performed according to the movement of the magnetic body (14), nucleic acid (13) is extracted from the surface of the magnetic bead (102) by the elution solution. This extracted nucleic acid (13) moves to the chamber (210) of the reaction chamber section (200) by driving the negative pressure generating device (250) and reacts with the reaction liquid (10).

[0236] In the embodiments illustrated in FIGS. 26a to 26c, the diagnostic cartridge (1) is equipped with a separate reagent supply unit (300) to supply reagent into the compartments (110a, 110b, 110c, 110d, 110e), but the present invention is not limited to the above-described embodiments.

[0237] For example, FIG. 27 illustrates an embodiment in which the reagent supply unit (300) is not used. In each compartment (110a, 110b, 110c, 110d, 110e) of the cartridge body (100), a reagent (11) suitable for the treatment to be performed in each compartment is filled in advance. In this case, it is preferable to provide a cover (113), such as a sealing film, that covers the open upper portion of each compartment (110a, 110b, 110c, 110d, 110e) so that the reagent (11) contained in each compartment (110a, 110b, 110c, 110d, 110e) does not come into contact with the outside. The cover (113) can be detached from the cartridge body (100) by the user at the start of diagnosis. In addition, the bottom surface of the cartridge body (100) comes into contact with the ultrasonic generating module (5) of the analysis device through the lower cover (101) of the cartridge body, which is made of a metal film such as aluminum to efficiently transmit ultrasonic waves, and the ultrasonic waves formed by the ultrasonic generating module (5) are transmitted into each compartment (110a, 110b, 110c, 110d, 110e) to help with the processing performed in each compartment.

[0238] Meanwhile, in order to move the sample component attached to the magnetic bead (12) contained in compartment (110a) together with the magnetic bead (12) between the remaining compartments (110a, 110b, 110c, 110d, 110e), a magnetic body (14) is directly inserted into each compartment (110a, 110b, 110c, 110d, 110e).

[0239] At this time, as illustrated in FIG. 27, a magnetic cover sleeve (15) may be additionally provided to prevent contamination of the magnetic body (14) and to facilitate the removal and addition of magnetism. The magnetic cover sleeve (15) may be pre-accommodated in a magnetic cover sleeve receiving space (112) formed inside the cartridge body (100). Preferably, a magnetic cover sleeve retaining part (113) may be formed in the magnetic cover sleeve receiving space (112) so that the tip of the magnetic cover sleeve (15) can be inserted and retained.

[0240] The transfer mechanism of the magnetic bead (12) using the above-mentioned diagnostic cartridge is described in detail as follows.

[0241] First, ultrasonic waves generated by the ultrasonic generating module (5) are transmitted into the compartment (110a) to mix the reagent (11) and the sample, and to crush the sample so that components derived from the sample are attached to the magnetic beads (12). After that, the tip of the magnetic body (14) is inserted into the magnetic body cover sleeve (15) received in the magnetic body cover sleeve receiving space (112) by the magnetic bead transfer module (3) of the analysis device. Then, when the magnetic body (14) is moved by the magnetic bead transfer module (3) of the analysis device, as shown in FIG. 27, the magnetic body (14) enters the compartment (110a) with the magnetic body cover sleeve (15) attached to its tip. Then, the magnetic beads (12) with components derived from the sample attached are directly attached to the magnetic body cover sleeve (15) by the magnetic force of the magnetic body (14). With the magnetic bead (12) attached, the magnetic body cover sleeve (15) moves into the next compartment (110b), and then the magnetic body (14) is separated from the magnetic body cover sleeve (15), leaving only the magnetic body cover sleeve (15). To do this, preferably, the analysis device is provided with a separate gripping mechanism capable of gripping the magnetic body cover sleeve (15), and while the magnetic body cover sleeve (15) is gripped by the gripping mechanism, the magnetic body (14) can be separated from the magnetic body cover sleeve (15) by using the magnetic bead transfer module (3) to retract the magnetic body (14) upward. Meanwhile, after the magnetic body (14) is separated, the magnetic force acting on the magnetic bead (12) through the magnetic body cover sleeve (15) disappears, so the magnetic bead (12) is separated from the magnetic body cover sleeve (15). After that, the reagent (11) and the magnetic bead (12) in the corresponding compartment are brought into contact so that processing is performed in the corresponding compartment. In this process, ultrasonic waves generated by the ultrasonic generating module (5) can be transmitted to mix the sample and facilitate processing.By repeating this process, the magnetic beads (12) are moved between each compartment to perform treatment, and then the nucleic acid (13) is extracted from the magnetic beads to which the final treated sample is attached and transferred to the reaction chamber (200).

[0242] Structure of the analysis device

[0243] Hereinafter, an analysis device according to a preferred embodiment of the present invention will be described with reference to FIGS. 28 to 30.

[0244] FIG. 28 is a block diagram showing the configuration of an analysis device according to a preferred embodiment of the present invention, FIG. 29a and FIG. 29b are a top view and a side view of an analysis device according to a preferred embodiment of the present invention, FIG. 30 is an enlarged front view of the stage, magnetic bead transfer module and ultrasonic generation module portions of the configuration of the analysis device shown in FIG. 29a and FIG. 29b, and FIG. 31 is an enlarged front view of the stage, sound pressure generation module, temperature control module and fluorescence detection module portions of the configuration of the analysis device shown in FIG. 29a and FIG. 29b.

[0245] An analysis device according to a preferred embodiment of the present invention relates to an analysis device using a diagnostic cartridge (1) described with reference to FIGS. 1 to 27, and may comprise a stage (2) on which the diagnostic cartridge (1) is mounted as shown in FIG. 28, a magnetic bead transfer module (3) for transferring a magnetic bead (12) contained within a compartment (110a) of the diagnostic cartridge (1) between each compartment (110a, 110b, 110c, 110d, 110e) of the diagnostic cartridge (1), a fluorescence detection module (4) for optically detecting fluorescence of a plurality of wavelengths according to a reaction in a reaction chamber (200), an ultrasonic generation module (5) for providing ultrasonic waves into at least one of the cartridge body (100) and the reaction chamber (200), and a control unit (8) for integrally controlling the stage (2), the magnetic bead transfer module (3), the fluorescence detection module (4), and the ultrasonic generation module (5).

[0246] Additionally, preferably, it may further include a temperature control module (6) for applying heat or cooling to the reaction liquid (10) and thermoplastic material (240) within the reaction chamber (200), and a negative pressure generating module (7) for forming negative pressure in the flow path (220) of the diagnostic cartridge (1). The operation of the above-mentioned temperature control module (6) and negative pressure generating module (7) may also be controlled by a control unit (8).

[0247] The stage (2) provides a place where the diagnostic cartridge (1), which has entered the analysis device through the door (9), is placed. Various processing and analysis using the diagnostic cartridge (1) as described above are performed while it is placed on the stage (2). Preferably, the stage (2) is made of a material that allows the ultrasound generated from the ultrasound generating module (5) to be transmitted into the cartridge body (100) or reaction chamber (200) of the diagnostic cartridge (1) through the stage (2), or an opening may be formed in the stage (1) so that the ultrasound generating module (5) can come into direct contact with the diagnostic cartridge (1) placed on the stage (2).

[0248] The magnetic bead transfer module (3) is equipped with a magnetic body (14) at its tip and a transfer drive unit (3a) for moving the magnetic body (14) in the XYZ direction. The transfer drive unit (3a) is preferably formed by an actuator such as a linear motor and moves the magnetic body (14) in a horizontal direction parallel to a plane formed by the X-axis and Y-axis or in a Z-axis direction perpendicular to the XY plane. Through the operation of the transfer drive unit (3a) of the magnetic bead transfer module (3), the magnetic body (13, 14) can be moved in a desired direction as shown in FIGS. 26a to 27, so that the magnetic bead (12) can be transferred between the compartments (110a, 110b, 110c, 110d, 110e) of the cartridge body (100).

[0249] The fluorescence detection module (4) is a device for optically detecting fluorescence of multiple wavelengths resulting from a reaction within the reaction chamber (200). Preferably, the fluorescence detection module (4) uses a laser of a predetermined wavelength (e.g., 650 nm) to excite a labeling substance within the chamber (210) of the reaction chamber (200) and then detects the fluorescence of a predetermined wavelength that is emitted, and performs a diagnosis on the detected fluorescence emission light. The results of the diagnosis performed can be displayed through a display unit, such as a monitor not shown.

[0250] The ultrasonic generating module (5) is a device for generating ultrasonic waves through the vibration of the vibration part (5) and transmitting the generated ultrasonic waves into the compartment (110) of the cartridge body part (100) to help crush cells in the sample and mix the sample and the reagent (11), or transmitting ultrasonic waves into the chamber (210) of the reaction chamber part (200) to promote a reaction performed within the chamber (210). Preferably, as shown in FIG. 30, the ultrasonic generating module (5) may be equipped with a transfer drive part (5b), such as the transfer drive part (3a) of the magnetic bead transfer module (3), at one end of the vibration part (5a). Through this, the contact position between the vibration part (5) of the ultrasonic generating module (5) and the diagnostic cartridge (1) can be precisely controlled, so that the vibration part (5) can come into contact with a specific compartment (110) within the cartridge body part (100) or a specific chamber (210) of the reaction chamber part (200).

[0251] The temperature control module (6) is a device for applying heat to or cooling the reaction liquid (10) and the thermoplastic material (240) within the reaction chamber (200). Preferably, the temperature control module (6) may include a Peltier element that performs heating or cooling by applying or absorbing heat to the reaction chamber (200), and a heat sink for releasing the cold or heat of the Peltier element. Meanwhile, the temperature range for solidifying or liquefying the thermoplastic material (240) and the preferred temperature range of the reaction liquid (10) during molecular diagnosis may differ from each other. Accordingly, preferably, the temperature control module (6) may be equipped with a first temperature control unit for transferring or recovering thermal energy to or recovering the reaction liquid (10) within the reaction chamber (200), and a second temperature control unit for transferring or recovering thermal energy to or recovering the thermoplastic material (240) that seals the flow path (220) of the reaction chamber (200). For example, a first Peltier element is provided as a first temperature control unit and a second Peltier element is provided as a second temperature control unit, and each can be controlled using a control unit (8) so that they are driven within different temperature ranges.

[0252] The negative pressure generating module (7) is a device for forming negative pressure in the flow path (220) of the diagnostic cartridge (1). As described with reference to FIG. 25a, when the diagnostic cartridge (1) is equipped with a syringe-type negative pressure generating device (250), the negative pressure generating module (7) may consist of a gripping part (7a) that grips the piston head (252) of the negative pressure generating device (250) of the diagnostic cartridge (1) and a lifting drive part (7b) for raising and lowering the gripping part (7a) in the up and down direction. The gripping part (7a) is equipped with a pair of claws facing each other, and grips the piston head (252) in a manner that supports the lower surface of the piston head (252) using the upper surface of the pair of claws. The lifting drive unit (7b) is a lifting device driven, for example, by a linear motor. When the lifting drive unit (7b) is used to raise the gripping unit (7a) while the piston head (252) is gripped by the gripping unit (7a), the piston head (252) is raised as a whole. Accordingly, the control unit (8) controls the operation of the lifting drive unit (7b) to adjust the amount of lifting of the gripping unit (7a), thereby appropriately controlling the amount of negative pressure generated within the flow path (220) due to the operation of the piston (251). However, the negative pressure generating module (7) is not limited to the example described above. For example, the negative pressure generating module (7) may be a vacuum pump connected to the outlet (230) of the reaction chamber (200) of the diagnostic cartridge (1) through a pressure transmission hose. In this case, the control unit (8) can control the amount of negative pressure generated within the flow path (220) by controlling the operation of the vacuum pump.

[0253] The control unit (8) is a device for integrally controlling the aforementioned stage (2), magnetic bead transfer module (3), fluorescence detection module (4) and ultrasonic generation module (5), temperature control module (6) and sound pressure generation module (7). Preferably, the control unit (8) may be composed of a computer having a CPU as a central processing unit, a memory unit (RAM and ROM) for storing data or programs, and input and output ports for inputting and outputting signals between external devices. The control unit (8) controls each component of the analysis device by having the CPU execute various calculation processes based on a program stored in the memory unit.

[0254] Meanwhile, the analysis device may be equipped with an input unit (8a), such as a keyboard, which is connected to the control unit (8) through an input port of the control unit (8) to obtain input instructions from the user. The control unit (8) may receive information from the user through the input unit (8a) regarding at least one of the following: the type of diagnosis performed using the diagnostic cartridge (1), the shape of the diagnostic cartridge (1), the type of sample contained within the diagnostic cartridge (1), and the type of reagent contained in a plurality of compartments (110a, 110b, 110c, 110d, 110e). Based on the received information, the control unit (8) may control at least one of the stage (2), the magnetic bead transfer module (3), the fluorescence detection module (4), the ultrasonic generation module (5), the temperature control module (6), and the sound pressure generation module (7). For example, the control unit (8) receives information regarding the number and arrangement structure of the compartments (110) within the diagnostic cartridge (1) through the input unit (8a), and controls the position of the magnetic bead transfer module (3) based on the information so that the transfer of magnetic beads (12) by magnetic bodies (14, 15) can be accurately performed between each compartment (110). In addition, the control unit (8) receives information through the input unit (8a) regarding whether the analysis using the diagnostic cartridge (1) is molecular diagnosis or immunodiagnosis, and controls the fluorescence detection module (4) based on the information so that the labeling substance is excited in a manner suitable for each diagnosis and the fluorescence suitable for the diagnostic purpose can be detected. Additionally, the control unit (8) receives information such as the type of sample contained in the corresponding diagnostic cartridge (1) and the type of reagent contained in the plurality of compartments (110) through the input unit (8a), and controls the temperature control module (6) based on the information, thereby maintaining a temperature suitable for each sample or reagent.

[0255] Additionally, preferably, the analysis device may be equipped with a sensor (8b) capable of reading an information display unit (120) attached to a diagnostic cartridge (1). As previously described, the information display unit (120) may be a barcode containing information regarding at least one of the types of diagnosis performed using the diagnostic cartridge (1), the shape of the diagnostic cartridge (1), the types of samples contained in the diagnostic cartridge (1), and the types of reagents contained in a plurality of compartments (110a, 110b, 110c, 110d, 110e), and in this case, the sensor (8b) may be a reader capable of recognizing such a barcode. In this case, as previously mentioned, the user can automatically set parameters for controlling the stage (2), magnetic bead transfer module (3), fluorescence detection module (4) and ultrasonic generation module (5), temperature control module (6) and sound pressure generation module (7) by obtaining information from the corresponding information display unit (120) through the sensor (8b) without directly inputting the information of the diagnostic cartridge (1) used for analysis through the input unit (8a).

[0256] Although various embodiments of the present invention have been described above, the descriptions made so far are merely illustrative of some preferred embodiments of the present invention and are not limited by the foregoing except for those that may appear in the claims appended below. Accordingly, those skilled in the art should understand that the present invention allows for many changes, modifications, and substitutions of equivalents within the scope described in the following claims without departing from the technical spirit and essence of the invention.

[0257] The present invention relates to a diagnostic cartridge in which a cartridge body and a reaction chamber are integrally injection-molded, and is configured to transport multiple magnetic beads contained in any one of a plurality of compartments within the cartridge body between the plurality of compartments using a magnetic material through the space above the plurality of compartments.

[0258] Meanwhile, in a preferred embodiment of the present invention, a reagent supply unit is further included that is inserted and seated through the open upper portion of the cartridge body. The reagent supply unit is formed with a plurality of reagent chambers arranged side by side, each corresponding to a compartment of the cartridge body and containing a reagent to be supplied to each compartment within the cartridge body, with the lower portion sealed by a sealing film. Additionally, above each compartment, a hollow perforation portion surrounded by a wall is provided to perforate the sealing film. When the reagent supply unit is seated, the sealing film is perforated by the perforation portion, allowing the reagent to be supplied to the compartment.

[0259] According to the present invention, it is possible to manufacture a cartridge with a compact structure and low manufacturing cost while enabling analysis with high detection efficiency and detection accuracy.

[0260] Furthermore, according to the present invention, a diagnostic cartridge that can be universally used for molecular diagnosis and immunodiagnosis can be provided. Additionally, by detecting an information display unit on the diagnostic cartridge, the type of diagnosis using the diagnostic cartridge and the setting of driving control parameters for each module required for diagnosis can be automatically performed, thereby reducing the burden on the user in operating the analysis device and reducing the possibility of misdiagnosis.

Claims

1. A diagnostic cartridge comprising a cartridge body and a reaction chamber provided on one side of the cartridge body to react a fluid delivered from the cartridge body through a flow path with a reaction liquid contained in a chamber therein, The above cartridge body has a plurality of compartments arranged side by side within it, the upper surface of which is open, for accommodating supplied samples and reagents. At least one of the plurality of compartments is configured to accommodate a plurality of magnetic beads, and Above the plurality of compartments, a space communicating with the interior of the plurality of compartments is formed so that the magnetic beads can be transported between the plurality of compartments using a magnetic material, and A diagnostic cartridge characterized in that the cartridge body and the reaction chamber are integrally injection molded.

2. In Claim 1, A diagnostic cartridge injection-molded such that, among the plurality of compartments, the bottom surface of the cartridge body corresponding to the compartment directly connected to the chamber of the reaction chamber part through the flow path and the bottom surface of the reaction chamber part are on the same plane.

3. In Claim 2, The reaction chamber is a plate-shaped part in which at least one of its upper and lower surfaces is covered by a cover, and A diagnostic cartridge in which the above-mentioned Euro and the above-mentioned chamber are formed by injection molding inwardly concavely from the surface of the plate-shaped portion or by injection molding to penetrate the plate-shaped portion.

4. In Claim 1, The above Euro is, An inlet flow path having one end fluidly communicating with the compartment of the cartridge body and the other end fluidly communicating with the chamber, and It includes an outlet flow path, one end of which is fluidly connected to the chamber and the other end of which is connected to an external negative pressure generating device, A diagnostic cartridge in which at least one of the inlet path and the outlet path is sealed by an obstacle made of a thermoplastic material.

5. In Claim 4, The above reaction chamber section is, An injection port capable of injecting the above thermoplastic material from the outside and A diagnostic cartridge having a sealed channel, one end of which is connected to the injection port and the other end of which communicates with the inlet channel and the outlet channel.

6. In Claim 4, A diagnostic cartridge in which at least one of the inlet path and the outlet path is composed of a curved line comprising at least three curves bent at a predetermined angle.

7. In Claim 1, The above cartridge body part is, A microfluidic cartridge configured such that the magnetic body can enter the interior of the compartment from the open upper surface of the compartment through the space.

8. In Claim 1, It further includes a reagent supply unit inserted and seated through the open upper part of the cartridge body, and The above reagent supply unit has a hollow shape surrounded by walls corresponding to each compartment of the cartridge body, and a plurality of reagent chambers are formed side by side, with the lower ends sealed by a sealing film while the reagent to be supplied to each compartment within the cartridge body is contained inside the hollow. A diagnostic cartridge having a hollow perforation surrounded by a wall above each of the above compartments to perforate the sealing film.

9. In Claim 8, A diagnostic cartridge in which, when viewed from above, the outer surface of the wall of the hollow perforation has a shape corresponding to the inner surface of the hollow of the reagent chamber.

10. In Claim 8, A diagnostic cartridge having a slanted portion, wherein one end is connected to one of the wall portions constituting the perforation portion, the other end is connected to a side wall constituting the compartment, and extends downward at an angle to form a path through which the reagent flows from the reagent chamber into the compartment when the sealing film is perforated by the perforation portion.

11. In Claim 10, The cartridge body is injection molded so that the lower part of the above compartment is open, and When the above cartridge body is viewed from above, A diagnostic cartridge in which the side wall of the compartment connected to the inclined portion is offset toward the inclined portion from the wall of the perforation portion located above the side wall.

12. In claim 8, A diagnostic cartridge having an edge portion formed on the upper surface of the wall portion of the hollow perforation portion, the edge portion having a pointed portion protruding toward the sealing film of the reagent chamber.

13. In Claim 12, The pointed portion of the edge portion is formed along the perimeter of the wall portion of the hollow perforation portion when viewed from above, and A diagnostic cartridge having an edge portion formed to be inclined downward from the pointed portion toward the interior of the hollow of the perforation portion.

14. In Claim 12, Each compartment of the above-mentioned reagent supply unit has a flat lower surface facing the above-mentioned perforation, and A diagnostic cartridge configured such that the heights of a pair of opposing walls among the walls of the above-mentioned hollow perforation are different from each other, so that another pair of walls extending between the pair of walls forms an inclined portion.

15. In Claim 14, A diagnostic cartridge in which the upper surface of the lower wall portion among a pair of wall portions configured with different heights of the perforation portion is not formed with the edge portion.

16. In Claim 13, A diagnostic cartridge, wherein the edge portion further comprises an inclined portion formed to be inclined downward from the pointed portion toward the outside of the hollow of the perforation portion.

17. In Claim 12, A diagnostic cartridge having at least one sawtooth-shaped protrusion protruding toward the sealing film of the reagent chamber, wherein the pointed portion of the edge portion has at least one sawtooth-shaped protrusion.

18. In Claim 1, The reaction chamber is a plate-shaped part in which at least one of its upper and lower surfaces is covered by a cover, and The above-mentioned Euro is formed by injection molding so as to be concave inward from the surface of the plate-shaped portion, or is formed by injection molding so as to penetrate the plate-shaped portion. A diagnostic cartridge, wherein the chamber is injection molded to protrude downward from the lower surface of the plate-shaped portion, the bottom surface of the chamber is formed to be located lower than the lower surface of the plate-shaped portion, and the upper portion is a hollow member that is open through the upper surface of the plate-shaped portion.

19. In Claim 18, The above chamber is a diagnostic cartridge having a structure in which the lower part is open and the open lower part is covered by a cover.

20. In Claim 1, The above Euro is, An inlet flow path having one end fluidly communicating with the compartment of the cartridge body and the other end fluidly communicating with the chamber, and It includes an outlet flow path, one end of which is fluidly connected to the chamber and the other end of which is connected to an external negative pressure generating device, A diagnostic cartridge having a valve capable of opening and closing the inlet passage in the above-mentioned inlet passage.

21. In claim 20, The above valve is, A valve seat that opens and closes the interior of the said path by moving back and forth toward the said path, A piston portion extending in the vertical direction from the above valve seat and A diagnostic cartridge having a piston head provided at the end of the piston portion facing the valve seat.

22. In claim 20, The above-mentioned sound pressure generating device is, A diagnostic cartridge configured to generate a pressure difference between the inlet passage and the outlet passage within the reaction chamber by gripping and extending the piston head of a piston connected to the outlet passage of the reaction chamber.

23. In Claim 1, The above reaction chamber section is equipped with a plurality of the above chambers, and The above-mentioned flow path includes a plurality of inlet flow paths connected to each of the compartments of the cartridge body and the plurality of chambers, and Each of the above plurality of inlet passages is, One end is connected to the first inlet passage of the above compartment, and, A second inlet passage located above the first inlet passage when viewed from the side, with one end connected to the chamber, and A diagnostic cartridge comprising a third inlet passage that connects the first inlet passage and the second inlet passage to each other and extends upward.

24. In Claim 1, The above diagnostic cartridge is a diagnostic cartridge used for molecular diagnostics or immunodiagnostics.

25. An analysis device that performs a diagnosis using a diagnostic cartridge according to claim 1, A stage on which the above diagnostic cartridge is mounted; A magnetic bead transfer module for transferring the magnetic bead within the diagnostic cartridge using the magnetic material; A fluorescence detection module for optically detecting fluorescence of multiple wavelength ranges resulting from the reaction of the reaction solution within the reaction chamber; An ultrasonic generating module for providing ultrasound into the interior of at least one of the cartridge body and reaction chamber; and An analysis device characterized by including a control unit for controlling at least one of the above stage, the above magnetic bead transfer module, the above fluorescence detection module, and the above ultrasonic generation module.

26. In Claim 25, It further includes a temperature control module for controlling the temperature inside the reaction chamber of the above diagnostic cartridge, and The above temperature control module comprises a first temperature control unit for transferring or recovering thermal energy inside the chamber of the reaction chamber and a second temperature control unit for transferring or recovering thermal energy to a thermoplastic material that seals the flow path of the reaction chamber.

27. In Claim 25, The above control unit is, Information regarding at least one of the type of diagnosis performed using the diagnostic cartridge, the shape of the diagnostic cartridge, the type of sample contained within the diagnostic cartridge, and the type of reagent contained within the compartment is received by receiving direct input from a user through an input unit or by reading an information display unit displayed on the diagnostic cartridge through a sensor. An analysis device that controls at least one of the stage, the magnetic bead transfer module, the fluorescence detection module, and the ultrasonic generation module based on the above input information.

28. A diagnostic cartridge that uses magnetic beads to perform processing while transferring a sample between a plurality of compartments containing a reagent within the cartridge body, and transfers the processed sample to a reaction chamber to react with a reaction solution. A diagnostic cartridge characterized in that the cartridge body and the reaction chamber are integrally injection molded.